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CHAPTER 1 
INTRODUCTION 
 
1.1 Mitochondria: It is All About Energy and Free Radicals 
The mitochondrion is a cellular power generator that supplies metabolism with different 
molecular building blocks and energy in a form of adenosine triphosphate (ATP) for movement 
and growth. It is a double membrane organelle found in the cytoplasm of all eukaryotic organisms. 
The outer mitochondrial membrane covers the organelle and is 60 to 75 Angstroms (Å) thick. The 
membrane is freely permeable to small molecules and contains many special channels, formed by 
the integral protein porin, for the transport of large molecules. The inner membrane forms 
numerous folds and creates layered structures, called cristae. Compared to the outer membrane, 
the inner membrane is much less permeable and more selective. The inner membrane is rich in a 
mitochondria-specific phospholipid, cardiolipin, that contains four fatty acid chains and plays a 
role in membrane impermeability. The space between the outer membrane and the inner membrane 
is called the intermembrane space. One protein that is localized in the intermembrane space is 
Cytochrome c (Cytc), an electron carrier that plays an essential role in the electron transport chain 
(ETC). The compartment enclosed by the inner membrane, called the matrix, contains a large 
number of mitochondrial proteins and enzymes. Mitochondria are unique organelles; they have 
their own DNA and their own ribosomes, which can be found in the matrix. Human circular 
mtDNA contains 16,569 bp and encodes 2 rRNAs, 22 tRNAs, and 13 proteins.  In humans, 
mitochondria are inherited maternally. 
The primary function of mitochondria is to generate ATP through respiration, and to 
regulate cellular metabolism. Most of the energy released from the breakdown of carbohydrates or 
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lipids is derived by oxidative phosphorylation (OXPHOS), a process of ATP formation by a series 
of electron carriers that takes place inside mitochondria. In the inner mitochondrial membrane, 
these carriers constitute the ETC and comprise four membrane-bound complexes: NADH 
dehydrogenase (complex I), succinate dehydrogenase (complex II), the non-protein electron 
carrier ubiquinone, bc1-complex (complex III), Cytc, cytochrome c oxidase (COX; complex IV), 
and ATP synthase that generates ATP. During oxidative phosphorylation, electrons are transferred 
from electron donors (NADH and FADH2) to a terminal electron acceptor (O2) via a series of 
oxidation-reduction reactions. In the ETC, two electrons from oxidized NADH, a product of the 
Krebs cycle, enter the ETC at complex I. These electrons are transferred from NADH to flavin 
mononucleotide followed by transfer through Fe-S clusters to coenzyme Q (ubiquinone). 
Ubiquinone, a small lipid-soluble molecule, in turn, passes electrons from complex I to complex 
III. Electrons are transferred from cytochrome c1 to Cytc, a small globular hemeprotein that carries 
a single electron from complex III to complex IV. At the end of the chain, COX passes electrons 
to the final electron acceptor, a molecule of oxygen, which is reduced to water. In parallel to 
complex I, complex II accepts electrons from succinate, a citric acid cycle intermediate. Electrons 
are transferred to coenzyme Q through the electron donor FADH2, and then to complex III and IV 
as described above. Passage of electrons through the ETC releases energy which creates a proton 
gradient. This gradient creates a mitochondrial membrane potential (ΔΨm) across the inner 
mitochondrial membrane by actively "pumping" protons into the intermembrane space via 
complexes I, III, and IV. The generated transmembrane proton gradient is used to produce free 
energy and drives the phosphorylation of ADP (adenosine diphosphate) to ATP. It has long been 
known that ΔΨm is also directly linked to free radical production. Under healthy conditions, ΔΨm 
is maintained around 120 mV which is sufficient for efficient generation of ATP (Kaim and 
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Dimroth, 1999). The production of reactive oxygen species (ROS) increases exponentially when 
the level of ΔΨm exceeds reach 140 mV (Liu, 1999). 
There is a small percentage of electrons (0.1–2%) that do not complete their pathway in 
the ETC and directly leak to oxygen, partially reducing oxygen to the superoxide anion (O2−•). 
Electron leakage takes place when electrons passing through the ETC exit prior to the reduction 
of oxygen to water at COX. Complexes I, III, and ubiqui-semiquinol are the main mitochondrial 
radical sources. Complex I is a major site of the production of mitochondrial ROS in vivo, and 
complex III is considered a minor source of superoxide (Jastroch et al., 2010). 
Electrons reacting with oxygen cause the production of free-radical superoxide, a highly 
reactive molecule. Although superoxide is a weak oxidant, it is a precursor for other ROS. 
Superoxide can be dismutated to hydrogen peroxide, which in turn may be fully reduced to H2O 
or partially reduced to hydroxyl radical (OH•), a powerful oxidant. Superoxide can also react with 
nitric oxide (NO•) to produce peroxynitrite which is one of the strongest oxidants (Beckman and 
Koppenol, 1996). Superoxide plays an essential role in oxidative stress. A high concentration of 
superoxide causes oxidative damage to proteins, lipids, and DNA due to their high reactivity 
towards such cellular compounds. The accumulation of damage can lead to mitochondrial 
dysfunction that has been implicated in many diseases such as cancer, neurodegenerative disease, 
heart failure, and aging. 
 
1.2 Mitochondrial Protein Cytochrome c Plays an Essential Role in Mitochondrial Function  
Cytochrome c (Cytc) is a small, 12.4 kDa globular multifunctional hemeprotein which is 
involved in cell life and death decision making processes. In humans and other mammalian species 
the mature Cytc contains 104 amino acids. Compared to other cytochrome proteins, Cytc is highly 
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water-soluble and positively charged (pI = 9.6). Cytc is conserved in many species, including 
plants, animals, and unicellular organisms. The sequences of human and chimpanzee Cytc are 
identical and differ from those of other mammals by only several amino acids (Hüttemann et al., 
2003).  
Cytc is located in the mitochondrial intermembrane space under normal conditions, and is 
encoded by the nuclear gene CYCS in human (Lee et al., 2006). The protein is synthesized as an 
inactive precursor, called apocytochrome c, and translated in the cytoplasm. During the 
translocation to the mitochondria, the heme group is covalently attached to cysteines 14 and 17 of 
side chains of the protein via thioether bonds. The heme iron exists in a hexacoordinate 
configuration comprising four nitrogen atoms in the heme and the His 18 and Met-80 residues. 
 
1.3 The Origin of Cytochrome c  
Cytc was first discovered in 1884 by MacMunn. His microspectroscopic studies on tissue 
samples from different organisms suggested that heme proteins play a crucial role in cellular 
respiration.  McMunn named the pigment from muscles myothaematin and histohaematin from 
other tissues. His discovery demonstrates that the mechanism of energy production takes place in 
tissue and cells. Later, respiratory pigments were rediscovered in 1925 by David Keilin, who 
renamed them as cytochromes, or “cellular pigments”.  He discovered that heme proteins were 
present not only in plants and animals, but also in yeast and bacteria. David Keilin believed that 
Cytc could function as an electron carrier by undergoing oxidation-reduction reactions as it 
contains a Fe atom. Thereby, he proposed a model for the basics of the respiratory chain, or ETC.  
Based on their lowest energy absorption band position in the reduced state, he classified these 
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proteins as cytochromes a (605 nm), b (~565 nm), and c (550 nm). The further classification of 
Cytc was done later, in 1991 by R. P. Ambler (Table 1).  
 
Table 1. Classification and characteristics of Cytochrome c  
Class Characteristics  
I Mitochondrial and bacterial lowspin soluble Cytc.  The heme-attachment site is 
towards the N-terminus of the His residue, and the sixth ligand provided by a Met 
is towards the C-terminus. 
II Compared to the class I, it is a high spin Cytc, which has the heme-attachment site 
close to the N-terminus of His residue. 
III The class includes the low redox potential multiple-heme cytochromes. The heme 
c groups are structurally and functionally nonequivalent. The group presents a vast 
range of redox potentials from 0 to −400 mV. 
IV This group includes the protein complexes which have other prosthetic groups in 
addition to heme c. 
 
1.4 The Structure of Cytochrome c  
One of the first crystalized proteins was Cytc from horse heart. The Cytc heme prosthetic 
group is covalently attached to the protein via two thioether bonds to cysteine residues. The 
conjugated ring system (Figure 1) of the heme group that surrounds a Fe ion allows the electrons 
to be very mobile. The iron ion interconverts between Fe2+ (reduced) and Fe3+ (oxidized) states, 
therefore, Cytc is able to perform oxidation and reduction reactions. 
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Figure 1. Ribbon model of horse cytochrome c. The heme group is shown in dark red. Essential 
amino acids for Apaf-1 binding and activation of caspase are shown in yellow. The picture is taken 
from (Yu et al., 2008). 
 
 
Figure 2. Absorption and CD spectra of cytochrome c-554 from Methylosinus trichosporium 
OB3b. In the reduced spectrum, the α-band has a maximum absorbance at 554 nm.  In the oxidized 
spectrum, a characteristic 695 nm absorption band indicates the ligation of Met-80 to the heme 
group. This band is called a “marker of Cytc integrity”. The picture is taken from (Harbitz and 
Andersson, 2011). 
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Methionine 80 and Histidine 18 coordinate the iron of the heme group. The bond between 
the iron of the heme group and Met-80 residue results in a weak 695 nm absorption band in the 
oxidized Cytc spectrum (Figure 2). This peak called as an “indicator of trouble” (Dickerson and 
Timkovich, 1975) since it is usually lost at any harmful treatment, and the lack of which suggests 
that the protein folded incorrectly. 
 
1.5 The Functions of Cytochrome c  
The functional importance of Cytc has long been recognized and it has been widely 
investigated in more than 20,000 studies. Cytc is an essential protein as it is involved in cellular 
life and death decisions. As part of the mitochondrial ETC Cytc is essential for electron transfer 
and the energy production process. It plays a crucial role in apoptosome formation and the 
progression of programmed cell death. Cytc also participates in cardiolipin peroxidation, ROS 
scavenging and formation, regulation of cell signaling pathways, and redox coupled protein import 
(Hüttemann et al., 2011; Kagan et al., 2005; Li et al., 2000a; Pecina et al., 2010). 
 
1.5.1 The Role of Cytochrome c in Respiration and Energy Production  
Energy is essential to life and all living organisms. ATP is a high-energy molecule and 
considered as the energy currency of life. ATP contains adenosine and three phosphates with high-
energy bonds, the breakdown of which liberates energy for all biological processes. On average, a 
70-kg person makes about 40 kg of ATP per day. About 90% of cellular ATP is generated by the 
OXPHOS machinery, which is located in the inner mitochondrial membrane and consists of the 
ETC and ATP synthase. During electron transfer in the ETC, complexes I (NADH 
dehydrogenase), III (bc1 complex), and IV (cytochrome c oxidase, COX) pump protons from the 
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matrix into the intermembrane space, generating the mitochondrial membrane potential (ΔΨm). 
ATP synthase (complex V) uses the membrane potential to drive the phosphorylation of ADP to 
ATP (Stock et al., 1999). 
In the final step of ETC, Cytc functions as a single electron carrier between complex III 
and IV. Four electrons are required to reduce a molecule of oxygen to water which is accompanied 
by a free energy change of ΔGo’= -100 kJ/mol (Hinkle et al., 1991). Under physiological 
conditions, this reaction is the rate-limited step of the ETC (Acin-Perez et al., 2003; Dalmonte et 
al., 2009; Villani and Attardi, 1997; Villani et al., 1998) and fundamental for the generation cellular 
energy in the form of ATP. Consequently, Cytc is essential for aerobic energy production and Cytc 
knockout mice die around midgestation, when a switch from glycolysis to respiration occurs (Li 
et al., 2000b). 
 
1.5.2 The Role of Cytochrome c in the Programmed Cell death  
Cytc plays a second role in type II (intrinsic) apoptosis. For the first time, the importance 
of Cytc in the apoptotic pathway was demonstrated in a cell-free apoptotic system in 1996 by Liu 
et al. (Liu et al., 1996). Another study suggested that Cytc undergoes molecular changes during 
programmed cell death (Krippner et al., 1996). 
Apoptosis, or programmed cell death, is an essential physiological mechanism that plays a 
crucial role in developing and maintaining the health of an organism, eliminating old and unhealthy 
cells. There are two main apoptotic pathways: type I - the extrinsic or death receptor pathway, and 
type II - the intrinsic or mitochondrial pathway. In the intrinsic apoptotic pathway, intracellular 
stress transduces signals to the mitochondria to release apoptogenic factors into the cytosol and 
initiate programmed cell death (Figure 3). The BCL-2 family protein is involved in the regulation 
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of apoptosis, pro-and anti-apoptotic proteins activate and inhibit apoptosis, respectively. Pro-
apoptotic members of Bcl-2 family proteins, such as Bax and Bak, acting on the mitochondrial 
permeability transition pore (mPTP), trigger the release of mitochondrial apoptogenic factor Cytc 
into the cytosol, leading to caspase activation. After entering the cytoplasm, Cytc binds to 
apoptotic protease-activating factor 1 (Apaf-1), which results in an increased affinity of the 
complex for dATP. This binding is crucial for the formation of the apoptosome (Wang, 2001). The 
apoptosome in turn recruits procaspase-9, initiating its cleavage to an active form. Activated 
caspase-9 then acts as the cleavage factor of caspase-3 (Green, 2000).  
Hundreds of studies have demonstrated the essential role of Cytc in apoptosis. In 2000, Li 
et al. confirmed that Cytc is crucial for caspase activation. Using cell lines null for Cytc, it was 
shown that caspase-3 activity was reduced when stimulated with apoptosis-inducing agents (Li et 
al., 2000a). A recent study has reported that Cytc Lys72 is critical for apoptosis (Hao et al., 2005). 
A mouse model with a Lys72Ala mutation had healthy respiration but was unable to initiate 
oligomerization of Apaf-1, and thus, was deficient in healthy apoptotic function. The Lys72Ala 
mutant mice were embryonic lethal (Hao et al., 2005). In 2000, Kluck et al. confirmed that in cell-
free systems, trimethylation of Cytc Lys72 inhibits the ability of the protein to activate caspases 
while maintaining normal oxidative phosphorylation level (Kluck et al., 2000). 
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Figure 3. The intrinsic, or mitochondrial type II apoptosis. The intrinsic apoptotic pathway 
involves the release of the apoptosis-triggering Cytc into the cytosol, binding to Apaf-1, and 
activation of caspase cascade. The picture is taken from (Wagner, 2005). 
 
1.5.3 Cytochrome c as a Radical Scavenger and Producer 
Oxygen is essential to humans and all other obligate aerobic organisms. Oxygen is required 
for the breakdown of complex food molecules into simpler substances and for the conversion of 
their stored energy into ATP. During normal mitochondrial oxidative metabolism, electron transfer 
reactions with oxygen that occur at the ETC complexes generate toxic byproducts - ROS, including 
superoxide (O2
•–), hydrogen peroxide (H2O2), and hydroxyl radicals (•OH) (Cadenas and Davies, 
2000; Kadenbach et al., 2004). ROS is generated mostly by complex I which releases them into 
the matrix, complex III that primarily releases ROS into the intermembrane space, and by the 
reduced ubiquinol pool (Han et al., 2003; Han et al., 2001; Turrens et al., 1985). ROS are highly 
reactive and can damage DNA or RNA, oxidize polyunsaturated fatty acids in lipids and amino 
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acids in proteins. Thus, ROS play an important role in pathogenesis of different diseases, such as 
neurodegenerative and cardiovascular diseases, ischemia reperfusion injury, and aging.   
Aerobic organisms have integrated antioxidant systems that can neutralize the toxic effects 
of ROS and protect an organism. The main enzymatic antioxidants are superoxide dismutase 
(SOD), catalase, and glutathione peroxidase (GSH-Px). There are three forms of SOD, CuZn-SOD, 
EC-SOD, and mitochondrial Mn-SOD. The superoxide molecules are reduced to hydrogen 
peroxide by SOD. H2O2 produced by the action of SOD is further reduced to a molecule of water 
by catalase and the GSH-Px. 
Free Cytc is capable of functioning as a radical scavenger within the inner-membrane space 
(Korshunov et al., 1999). The enzyme can regenerate O2 by removing the unpaired electron 
(Pereverzev et al., 2003). These electrons can be transported to COX for ATP production and 
regenerate the oxidized form of Cytc. Both the reduced and oxidized form of Cytc can function as 
a hydrogen peroxide scavenger (Wang et al., 2003).  
Furthermore, Cytc can produce ROS. p66Shc is one of three isoforms of ShcA (Src 
homologous- collagen homologue) adaptor protein family together with p46Shc and p52Shc. p66Shc 
is a small protein (66 kDa) that mostly localized in mitochondria where it alters mitochondrial 
function (Nemoto et al., 2006). p66Shc regulates the generation of ROS, induction of apoptosis, and 
lifespan in mammals. The protein’s functions are regulated via reversible phosphorylation (Pinton 
et al., 2007). During cellular stress, receiving an electron from Cytc, p66 is reduced and generates 
hydrogen peroxide (Giorgio et al., 2005). The production of ROS via the p66Shc apoptotic pathway 
contributes to the increased levels of peroxide that is essential for cardiolipin peroxidation by Cytc. 
Cardiolipin peroxidation is critical for the release of Cytc into the cytosol during the apoptosis. 
The release of Cytc from the mitochondria correlates with the production of H2O2 by p66
Shc (Sun 
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et al., 2010), and could be an important switch utilized by a cell as an initiating event of apoptosis 
(Liu, 1999).  
 
1.5.4 Cytochrome c Catalyzes Cardiolipin Oxidation 
Cardiolipin is an important signature phospholipid of the inner mitochondrial membrane 
where the lipid is synthesized. It constitutes approximately 20% of the total mitochondrial lipid 
pool. The dimeric nature and diphosphatidylglycerol structure combined with four acyl chains 
make cardiolipin a unique mitochondrial lipid, that plays a crucial role in mitochondrial function 
and, regulation of aggregate structures, triggers apoptosis, and serves as a proton trap for oxidative 
phosphorylation. 
In animal cells, cardiolipin is involved in the process of programmed cell death (apoptosis) 
through its interaction with the death-inducing protein Cytc. Cytc is bound to the inner 
mitochondrial membrane by phospholipids: approximately 15-20% is bound to cardiolipin (Kagan 
et al., 2004; Schlame et al., 2000). Cytc binds to cardiolipin through two sites called the A-site and 
the C-site. Weak electrostatic interactions occur through the A-site, between negative phosphate 
groups of cardiolipin and positively charged lysine residues of Cytc. The tight and stable 
conformation through the C-site is achieved by hydrophobic interactions and hydrogen bonding 
between Cytc Asn52 residue and one of the cardiolipin acyl chains that fits into the Cytc pocket. 
Even high ionic strength solutions cannot remove the fraction of hydrophobic membrane-bound 
Cytc (Belikova et al., 2006). However, the interaction between Cytc and cardiolipin results in 
partial unfolding of the enzyme and conformational changes between the heme group and Met-80, 
making the bond weaker.  
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Kagan et al. discovered that during apoptosis, the trans-membrane transfer of cardiolipin 
decreases the affinity of Cytc for cardiolipin (Kagan et al., 2005). Cardiolipin prompts the 
peroxidase activity of Cytc by destabilizing its tertiary structure through hydrophobic interactions. 
Therefore, the level of free Cytc is increased in mitochondrial intermembrane space (Iverson and 
Orrenius, 2004). During the rupture of the mitochondrial outer membrane, free Cytc can be further 
released into the cytosol followed by activation of caspases (Kagan et al., 2005). In conclusion, 
Cytc plays an essential role in the regulation of apoptotic process (Hüttemann et al., 2011). 
 
1.5.5 Cytochrome c Plays Role in Redox-Coupled Protein Import via Erv1-Mia40 
The transport of the mitochondrial nuclear encoded proteins into the mitochondria is 
performed by TIMs and TOMs, the translocases of the inner and outer membranes (Rehling et al., 
2001). The proteins undergo folding and/or assembly into functional proteins by enzymes that 
convert the apo-form into a holo-form protein. Cytc is imported into the mitochondrial 
intermembrane space as apocytochrome c that is synthesized from its nuclear gene. Cytc heme 
lyase or holocytochrome-c synthase converts the apo-form of Cytc to the holo-form by the addition 
of a heme group (Dumont et al., 1991). Together with the transporters of the outer membrane 
(TOMs), Erv1, and Mia40 proteins, Cytc is required in the redox-coupled import of proteins 
containing twin CX3C and CX9C motifs into the mitochondrial intermembrane space. Transported 
proteins via TOMs go through post-import modifications such as alternative folding. After the 
Mia40 oxidation, the formation of disulfide bonds occurs between cysteine residues that change 
the tertiary structure of proteins (Chacinska et al., 2004). This process depends on oxidation by 
Erv1 which in turn requires the activity of Cytc (Allen et al., 2005). The electrons derived from 
the Mia40 import pathway to Cytc are injected into the ETC (Hüttemann et al., 2011). 
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1.6 Regulation of Cytochrome c and Other Mitochondrial Proteins by Post-Translational 
Modifications 
Considering the multiple roles of mitochondria in energy and ROS production and the 
central role of Cytc in respiration and apoptosis, their activity should be tightly regulated. 
Regulation of mitochondrial proteins is also required due to the differences in the cellular 
requirements between tissues and organs. Protein regulation can be achieved by several 
mechanisms, including gene expression and translation and post-translational modifications 
(PTMs). In multicellular organisms, cell signaling through PTMs is one of the most crucial 
regulatory pathways. 
 
1.6.1 Phosphorylation of Cytochrome c Regulates Respiration and Apoptosis 
 Despite numerous studies on Cytc, the fact that this mitochondrial protein is subjected to 
PTMs as a part of cell signaling has remained unknown for a long time. To date, a total of four 
phosphorylation sites of Cytc were unambiguously assigned to Tyr-97, Tyr-48, Thr-28, and Ser-
47 by immobilized metal affinity chromatography/nano-liquid chromatography/electrospray 
ionization mass spectrometry (IMAC/nano-LC/ESI-MS). 
 For the first time, in 2006, our lab reported that Cytc from cow heart is phosphorylated at 
Tyr-97, one of four tyrosine residues present in the protein (Lee et al., 2006). Cytc from cow heart 
was isolated under conditions that preserve the physiological in vivo phosphorylation status. 
Western analysis with phosphotyrosine-specific antibody revealed a strong signal suggesting that 
at least one out of the four tyrosine residues was phosphorylated. Only one specific 
phosphorylation site was assigned by IMAC/nano-LC/ESI-MS to Tyr-97. The phosphorylated 
Tyr-97 is located on the right side of the molecule.  Spectral analysis of phosphorylated Tyr-97 
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Cytc indicated a shift of characteristic 695 nm absorption band to 687 nm which was reversed after 
alkaline phosphatase treatment. The interactions between Met-80 and heme iron causes the 
characteristic 695 nm band; a shift of the band suggests alterations in the catalytic heme crevice 
and changes in Cytc functions. Furthermore, phosphorylated Cytc at the Tyr-97 residue exhibits 
enhanced sigmoidal kinetics compared to the SAP-dephosphorylated Cytc and shows inhibition of 
oxygen consumption with purified COX (Lee et al., 2006). 
 In 2008, another phosphorylation site of Cytc was identified by our group from cow liver 
by mass spectrometry on Tyr-48(Yu et al., 2008). The analysis of oxygen consumption with 
isolated cow liver COX demonstrated that phosphorylated Tyr-48 Cytc shows a hyperbolic 
response, similar to unphosphorylated Cytc. The activity of COX was approximately 50% 
decreased with Tyr-48 phosphorylated Cytc. Structurally, Tyr-48 faces towards the inside of the 
protein. Additional phosphorylation groups could change the protein structure and alter its 
function. In a continuation of the above study, Pecina et al. generated a phosphomimetic mutant 
of Cytc to determine the functional impact of phosphorylated Tyr-48 Cytc in vitro. The 
phosphomimetic substitution of Tyr48Glu mutant Cytc mimics the negative charge of in vivo 
phosphorylation; in addition, WT and Tyr48Phe variants were used as non-phosphorylated 
controls. The kinetic analysis indicated a hyperbolic response with a 30% decrease of maximal 
velocity for the phosphomimetic mutant compared to the WT (Pecina et al., 2010). Additionally, 
compared to the WT control, the phosphomimetic Cytc mutant revealed a reduced midpoint redox 
potential, by 45mV, and a decreased binding affinity to cardiolipin by 30%. More importantly, this 
study showed that phosphomimetic Tyr48Gln Cytc was unable to induce downstream caspase-3 
activation in vitro. The research data suggest that phosphorylation at Tyr-48 residue could function 
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as an antiapoptotic switch in vitro and might have a crucial impact on the understanding of 
molecular pathways underlying the ability of cancer cells to evade apoptosis (Pecina et al., 2010). 
 Two other phosphorylation sites, Cytc Thr-28 and Ser-47 from human skeletal muscle, 
were discovered by high-throughput phosphoproteomic MS analysis (Zhao et al., 2011). While the 
functions of Cytc Ser-47 phosphorylation remain unknown, phosphorylated Thr-28 demonstrated 
regulatory activity through the ETC in bovine and rat kidney tissue (Mahapatra et al., 2017). Thr-
28 is located near the heme crevice.  Isolated Cytc from bovine and rat kidney tissue is 
phosphorylated on Thr-28. Phosphorylated Cytc in vivo and phosphomimetic T28E mutant cause 
inhibition of respiration with purified COX.  
Intact cells expressing T28E phosphomimetic Cytc showed a 60% decrease in respiration 
activity, supporting the in vitro results with purified COX. Additionally, mitochondrial membrane 
potential and ROS levels in the intact Cytc knock-out cells showed reduced levels compared with 
WT, suggesting that the phosphomimetic mutant can protect cells. Furthermore, compared to 
previous studies on Tyr-48 phosphorylated Cytc, phosphorylated Thr-28 and WT were able to 
trigger caspase-3 activation, suggesting that Thr-28 does not influence the apoptotic function of 
Cytc. Phosphorylation, or in other words, the introduction of a negative charge at Thr-28 residue, 
improved protein stability and resistance to degradation in the presence of excess H2O2 compared 
to WT control. Considering that the reduction rate of oxidized Thr-28 mutant was twice the rate 
of WT, it was proposed that Thr-28 phosphorylated Cytc can function as an electron acceptor and 
ROS scavenger. Interestingly, the peroxidase activity of the phosphomimetic mutant was much 
lower compared to WT. The results of this study suggest that the regulation of ETC flux through 
Cytc phosphorylation prevents hyperpolarization of mitochondrial membrane potential to prevent 
the generation of ROS.   
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1.6.2 Methylation of Lysine Residues of Cytochrome c 
It has long been known that Lysine, Arginine, Histidine, and dicarboxylic amino acids can 
accept an additional methyl group. In the histones, the ε-NH2 group of Lysine residues can be 
mono-, di- or tri-methylated. Protein methylation regulates many biological functions, such as gene 
regulation and signal transduction (Paik et al., 2007). It was reported that a lysine ε-NH2 group of 
Cytc is methylated in vivo (Pahlich et al., 2006). Methylation of Cytc increases protein stability in 
vivo and supports resistance to proteolytic digestion in vitro (Paik et al., 2007). 
It has been shown in Saccharomyces cerevisiae and plants that Cytc expressed from the 
CYC1 gene is immediately trimethylated by the Cytc methyltransferase Ctm1p at an evolutionarily 
conserved Lys-78 residue (usually referred to Lys-72 by homology to vertebrates) (Holzschu et 
al., 1987; Paik et al., 1989). Although Cytc methylation does not usually occurs in higher 
organisms, it is an essential PTM in yeast. Trimethylation supports its transport into the 
mitochondrial inner membrane space (Park et al., 1987). Cytc methyltransferase Ctm1p is 
regulated by Cyc1p, and can carry electrons between complex III and complex IV in the ETC. 
Cyc1p also participates in the response to oxidative stress (Kwon et al., 2003; Volkov et al., 2011) 
and protein import into the mitochondrial intermembrane space in yeast (Dabir et al., 2007; Hell, 
2008; Herrmann and Riemer, 2012).  Methylation of Cyc1p could change its geometry, PI, or 
conformation (Brems and Stellwagen, 1981; Kim et al., 1980; Pollock et al., 1998). Additionally, 
a structural analysis demonstrated that trimethyllysine 78 is essentially positioned across the heme 
crevice loop, playing a crucial role in opening the crevice (Cherney et al., 2013). Later, in 2015, 
Winter et al. demonstrated that methylation of Cyc1p increases its interactions with Erv1p and 
Cyc3p. This supports the addition of the heme group to Cyc1p, hence trapping it in the 
mitochondrial intermembrane space (Winter et al., 2015).   
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Polastro et al. have shown that in Ascomycetes, methylation at Cytc Lysine72 residue 
maintains the binding of the hemoprotein to mitochondria. They concluded that methylation of the 
protein is essential for the physiological processes, including electron transport through the ETC 
(Polastro et al., 1978). Later, in 1980, Farooqui et al. reported that Cytc from fungi and plants is 
methylated by S-adenosylmethionine: cytochrome c-lysine N-methyltransferase. The group 
demonstrated that methylation of Cytc at the lysine residue protects the protein against the 
intracellular proteolytic enzyme attack in vivo (Farooqui et al., 1981). Furthermore, the 
methylation at Lys-72 Cytc showed the pro-apoptotic activity of the hemeprotein (Kluck et al., 
2000). 
 
1.6.3 Mitochondrial Lysine Acetylation 
Modifications of the lysine amino acid are crucial for mitochondrial physiology, owing to 
the localization of the specific metabolites in the mitochondrial matrix. Under physiological 
conditions, modification on the ε-amino group of lysine residues show a remarkable chemical 
diversity with about twenty modifications (Figure 4) (Hosp et al., 2017). Lysine acetylation is the 
most frequent PTM within mitochondria. In 2006, Kim et al. identified and analyzed 388 
acetylation sites on 195 proteins from isolated mouse liver mitochondria and HeLa cells (Kim et 
al., 2006). Recent studies have confirmed that the mitochondrial proteome is acetylated; more than 
60% of the proteins have one or more acetylation sites (Anderson and Hirschey, 2012; Hebert et 
al., 2013; Konig et al., 2014; Smith-Hammond et al., 2014).The TCA cycle, ETC, and ATP 
synthase are conserved targets for lysine acetylation in various species. It has been reported that 
isocitrate dehydrogenase 2 (IDH2), malate dehydrogenase (MDH), and succinate dehydrogenase 
(SDH) are found to be acetylated (Lin et al., 2014). Furthermore, skeletal muscle, heart, liver, and 
19 
 
 
 
brown fat tissue house the most mitochondria; and therefore, could be hyperacetylated. More than 
80% of the proteins participating in muscle contraction are acetylated, and over 15,000 lysine 
acetylation sites have been quantified in different rat tissues (Lundby et al., 2012). This evidence 
suggests that lysine acetylation is an essential PTM.  
 
Figure 4. The importance and the diversity of PTMs of lysine residue among mitochondrial 
proteins. The picture is taken from (Hosp et al., 2017). 
 
Unaltered lysine residues carry a positive charge which is essential for ionic interactions 
among proteins. Lysine acetyltransferase (KAT) uses acetyl-CoA as a substrate and transfers the 
acetyl moiety to the ε-group of a lysine residue. Acetylation of lysine masks or neutralizes the 
positive charge of the residue. This charge change usually has constructive effects on protein 
function, enzyme regulation, or protein stability, and can cause various diseases.  
 
1.7 Mitochondrial Acetylation in Human Diseases 
PTMs, particularly lysine acetylation, are crucial contributors to the mitochondrial defects 
and its functional depletion as discussed below. Acetylation, or deacetylation of lysine residues 
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directly affect mitochondrial functions and lead to different human illnesses, such as heart diseases, 
cancer, and neurodegenerative disorders.  
 
1.7.1 Mitochondrial Protein Hyperacetylation in the Failing Heart  
The energy stores of cardiomyocytes are limited; therefore, heart tissue requires a high 
level of ATP to maintain its contractive function. Mitochondrial dysfunction and energy depletion 
are linked to the impaired myocardial energetics, trigger oxidative stress and lead to the 
development of heart failure (HF) (Horton et al., 2016). Recent studies indicate that lysine 
acetylation of mitochondrial proteins contributes to the sensitivity of the heart to stress and cell 
death (Lee and Tian, 2015). In 2012, Grillon et al. identified a non-histone protein acetylation in 
the failing heart for the first time. In spontaneously hypertensive HF prone and Dahl salt-sensitive 
animal models, 66 and 41 acetylated proteins were found respectively (Grillon et al., 2012). This 
suggests a reduced level of SIRT3 in the failing heart.  SIRT3, mitochondrial NAD-dependent 
deacetylase, modulates cardiomyocyte resistance and survival during oxidative stress. Later, in 
2013, it was shown that the level of SIRT3 is dramatically decreased in the failing heart from rat 
(Chen et al., 2013) and that the progression of the disease was linked to the increased level of 
mitochondrial protein acetylation in the murine model of diabetic cardiomyopathy (Vadvalkar et 
al., 2013). 
Additionally, increased acetyl-CoA levels that were found in the human failing heart can 
drive acetylation of mitochondrial proteins, which in turn might trigger enzymatic dysfunction 
(Baeza et al., 2016). Based on these results, Horton et al. considered that during the progression of 
heart failure, aggregation of fuel oxidation pathway metabolic intermediates trigger PTMs of 
mitochondrial proteins. They showed that 82 out of 383 mitochondrial proteins were acetylated at 
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the 244 acetylated lysine sites seen in the cardiac hypertrophy and failing mouse heart. Progressive 
mitochondrial protein lysine acetylation take place in OXPHOS pathways, since most of the 
identified acetylated proteins are involved in the ETC, TCA cycle, and β-oxidation pathways 
(Horton et al., 2016). The authors also emphasized that succinate dehydrogenase A (SDHA), the 
only enzyme that participates in both the TCA cycle and the ETC, is hyperacetylated at several 
lysine residues in human and mouse samples. The mutagenesis study of acetyl-mimetic K179Q 
mutant reveals reduced catalytic function and lowered complex II-driven respiration (Horton et 
al., 2016). 
The collective results suggest that extensive mitochondrial protein lysine acetylation, 
driven by the increased level of acetyl-CoA and reduced NAD+ levels, leads to decreased oxidative 
flux, depletion of ATP, and hence to the development of HF. 
 
1.7.2 Impact of Acetylation on the Neurodegenerative Diseases 
 To date, Alzheimer disease (AD) is the most prevalent neurodegenerative disorder which 
is characterized by the intracellular accumulation of hyper-phosphorylated tau protein in neurons. 
Senile plaques in the brain are composed of β-amyloid (Aβ) aggregates, which can cause neuronal 
death. Most proteins that are involved in the progression of AD are targets of SIRT1 and regulated 
by lysine acetylation (Michan, 2013). Cognitive defects in vivo are usually the result of acetylation 
of human tau protein at Lys-174, Lys-274, and Lys-280 (Cohen et al., 2011). Additionally, the 
acetyl mimetic, tau K280Q, increased neurotoxicity in a Drosophila melanogaster model in vivo 
(Gorsky et al., 2016). 
Mitochondrial acetylation is also observed in Parkinson’s (PD) and Huntington's diseases 
(HD). In animal models of PD, acetylation triggers mitochondrial autophagy that is regulated by 
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PINK1 and Parkin proteins (Auburger et al., 2014). HD, a trinucleotide cytosine-adenine-guanine 
(CAG) repeat disorder, causes glutamine expansion (PolyQ). The Huntington protein (HTT) that 
is largely expressed in the brain regulates neurotransmission. Misfolded HTT causes protein 
aberration and the formation of aggregates, accumulation of which leads to the neuronal death. 
Michan et al. demonstrated that in Drosophila melanogaster, the mitochondrial global acetylation 
level could be reduced by the interactions between the polyQ stretches and the acetyltransferase 
domain of proteins (Michan, 2013).  In mouse brains, acetylation at the K444 residue of mutant 
HTT stimulates autophagy-mediated protein degradation and decreases neurotoxicity (Jeong et al., 
2009).  
  
1.7.3 Acetylation of Lysine Residues in Cancer Metabolism 
 PTMs are most commonly dysregulated in different types of cancer, including prostate 
cancer. In prostate cancer androgen signaling plays an essential role in triggering cancer cell 
proliferation (Carver, 2014). Cancer cells use mitochondria as signaling organelles, and 
mitochondria are required for cancer bioenergetics and biosynthesis of macromolecules (Weinberg 
and Chandel, 2015). Protein acetylation of intermediary metabolism could affect survival of cancer 
cells both, positively or negatively (Choudhary et al., 2009; Guan and Xiong, 2011; Kim et al., 
2006). Acetylation of pyruvate dehydrogenase phosphatase 1 (PDP1) at residue K202 and pyruvate 
dehydrogenase (lipoamide) alpha1 at residue K321 leads to enzymatic dysfunction and 
disassembly of the pyruvate dehydrogenase complex, promoting cancer cells to depend on 
glycolysis (Fan et al., 2014). Recent studies indicate that acetylation of proteins participating in 
glycolysis may alter cancer cell growth (Lv et al., 2011). Lysine acetylation of PKM2 inhibits 
enzyme activity and causes an aggregation of glycolytic intermediates to maintain tumor growth. 
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Acetylation of lactate dehydrogenase (LDH) at residue K5 has the opposite effect. Destabilization 
and reduced activity of acetylated enzymes leads to the depletion of the NAD+ pool in glycolysis. 
Additionally, lysosomal protein degradation and chaperone-mediated autophagy are triggered by 
interaction between acetylated LDH and the HSC70 chaperone protein. Deacetylation of LDH by 
SIRT2 supports the activation of the enzyme as well as pancreatic tumor growth in both in vitro 
and in vivo studies (Zhao et al., 2013). Another study on pancreatic cancer indicates that acetylation 
of mitochondrial glutamate oxaloacetate transaminase at K159, K185, and K404 residues enhances 
the interactions with malate dehydrogenase. These interactions elevate the activity of the malate-
aspartate shuttle to increase ATP production for the tumor growth (Yang et al., 2015). In addition 
to the pancreatic studies, lung cancer research reported that the acetyl-mimetic mutant Lys100Gln 
of phosphoglycerate mutase 2 (PGAM2) suppresses cell proliferation and cancer growth in A549 
lung cancer cell line and tumor xenografts in vitro and in vivo.   
 To maintain cell proliferation and tumor progression, cancer cells utilize increased lipid 
biosynthesis. Cytosolic acetyl-CoA required for lipogenesis is produced by the ATP-citrate lyase 
(Lin et al., 2013). Acetylation of the enzyme at K540, K546, and K554 stabilizes the protein and 
increases lipid synthesis. Therefore, acetylation at specific residues can enhance cell proliferation 
and cancer growth in vivo.   
 
1.8 Prostate Cancer  
Prostate cancer is one of the most common types of cancer in men and the second leading 
cause of cancer death among men in America. The American Cancer Society estimated that more 
than 220,800 men were newly diagnosed with this pathology in 2015, more than 27,540 men died 
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from the disease, and approximately 1 man in 7 will be diagnosed with prostate cancer during his 
lifetime.  
Prostate cancer, or carcinoma, is a disease of the prostate gland of the male reproductive 
system (Figure 5). A prostate is a small walnut-shaped exocrine gland which secretes a slightly 
alkaline seminal fluid that nourishes and transports sperm. Carcinoma begins with small alterations 
in the shape, size, and uncontrollable growth of the prostate gland cells, which are called prostatic 
intraepithelial neoplasia (PIN). Whereas most prostate cancers usually grow slowly, some types 
can be aggressive and grow relatively quickly. Additionally, these more aggressive types of 
prostate cancer might spread to other parts of the body, particularly the bones and lymph nodes. 
Almost all prostate cancers are adenocarcinomas; however, other rare types exist including 
sarcomas, small cell carcinomas, neuroendocrine tumors, and transitional cell carcinomas.  
Despite more than 70 years of cancer research, a full understanding of cancer cause has 
not yet been achieved. The past and current studies indicate some risk factors of prostate cancer, 
including age and a family history of the disease. The disease typically occurs in men over the age 
of 50 and having prostate cancer one’s family history increases the risk two to threefold for the 
individual. Other factors that might be involved in prostate cancer development are a diet high in 
processed and red meat, milk products, and low in certain vegetables. 
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Figure 5. Healthy prostate and prostate cancer. Prostate cancer is characterized by small 
alterations in the shape, size, and uncontrollable growth of the prostate gland cells. The picture is 
taken from Urology associates. https://denverurology.com/male-urology/prostate-cancer/ 
 
Prostate cancer is diagnosed by biopsy, however, one of the most problematic aspects of 
this pathology is that there are no symptoms in the early stages; therefore, it is difficult to diagnose 
it in time. Treatment modalities for prostate cancer range from surgery and radiation to 
chemotherapy. If left untreated, prostate cancer cells are able to spread by breaking away from a 
prostate tumor and moving through blood or lymph vessels. They may attach to other tissues, 
producing secondary tumors in a process known as metastasis.  
 
1.9 Metabolic Shift in Cancer: the Warburg Effect 
As compared to a healthy cell, the progression of cancer follows a metabolic change from 
depending primarily on mitochondrial respiration to depending primarily on glycolysis. This 
switch is known as the Warburg effect, or aerobic glycolysis (Warburg, 1956; Warburg et al., 
1924).  
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In the 1920’s a German biochemist and Nobel laureate, Otto Heinrich Warburg was 
characterizing the growth of rat hepatocarcinoma cells in vitro and observed that even in the 
presence of oxygen, most tumor cells exhibited an increased rate of glycolysis. He discovered that 
unlike most normal tissues, tumor cells convert the majority of glucose carbon to lactate in the 
cytosol (Figure 6), even in oxygen-rich conditions, hence the term is ‘aerobic glycolysis’. Warburg 
attributed this change to mitochondrial defects that he proposed inhibited their ability to effectively 
oxidize glucose carbon to CO2. He hypothesized that this altered metabolism is specific to cancer 
cells and it unleashes a potential etiology of cancer origins. However, newer research has shown 
that mitochondria are functional in most cancer cells; therefore, other mechanisms, such as 
metabolic reprogramming, may explain the reduced aerobic activity found in cancer (Ward and 
Thompson, 2012). 
 
Figure 6. Metabolic shift in cancer cells - the Warburg effect. Comparison of Glycolysis 
Between a Normal Tissue (total 38 ATP) and Tumour/Proliferated Tissue (total 4 ATP).  The 
picture is taken from (Vander Heiden et al., 2009). 
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In healthy, non-malignant cells, in the presence of oxygen, one glucose molecule is 
converted into pyruvate in the cytosol, then transported to the mitochondria where it is metabolized 
through the TCA cycle and finally the ETC, yielding 36 molecules of ATP. Warburg observed that 
cancer cells undergoing aerobic glycolysis and convert approximately 85% of glucose to lactate in 
the cytosol with limited ATP production (one molecule of glucose yields 2 molecules of ATP) but 
increased macromolecule production. This leads to a biosynthetic metabolic shift towards the 
pentose phosphate pathway (PPP) for the production of NADPH and ribose-5-phosphate to 
increase nucleotide synthesis. This is essential for the high proliferation rate seen in cancer cells.  
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CHAPTER 2 
THE EFFECT OF ACETYLATION OF CYTOCHROME C ON ITS FUNCTIONS IN 
CANCER 
 
2.1 Background and Purpose of Study  
Cytochrome c (Cytc) is a small multifunctional globular protein with a covalently attached 
heme group.  Cytc is involved in cellular life and death decisions. The protein is located in the 
mitochondrial intermembrane space, where it functions as an electron carrier between bc1 complex 
and COX in the ETC, playing an important role in the generation of cellular ATP. Cytc knockout 
mice die around midgestation, when a metabolic switch occurs from the glycolytic pathway to 
aerobic energy production. Additionally, Cytc plays another crucial role in type II apoptosis, which 
involves the release of Cytc from the mitochondria into the cytosol, where it activates downstream 
caspases after the formation of the apoptosome. We propose that all Cytc functions are regulated 
through cell signaling pathways. The three major functions of Cytc, (mitochondrial respiration, 
apoptosis, and ROS generation or scavenging) are all altered in cancer, leading to Warburg 
metabolism and evasion of apoptosis (Hüttemann et al., 2014). 
The importance of Cytc has long been recognized; however, the fact that it can be 
posttranslationally modified has remained unknown until recently. In the Hüttemann lab, it was 
shown that Cytc is posttranslationally modified by phosphorylation of tyrosine residues in healthy 
tissues on two distinct tyrosine residues in vivo, Tyr-97 and Tyr-48 in heart and liver tissue, 
respectively (Lee et al., 2006; Yu et al., 2008). Importantly, our preliminary data indicates that 
human Cytc is acetylated on lysine 53 (Lys-53) in castrate-resistant and castrate-sensitive prostate 
tumor xenografts. This is the first time that Cytc acetylation has been identified in mammals.  
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The results of mass spectrometry unambiguously assigned acetylation site on Lys-53 in 
both castrate-resistant and - sensitive tumors, therefore it has been proposed that the Cytc 
acetylation state changes from a “healthy” to a “cancer” state (Figure 7) in prostate cancer, where 
the Warburg effect causes the inhibition of the mitochondria respiration. The other hypothesis was 
that the acetylation of Cytc prevents the involvement of Cytc in cell death in cancer.  
 
 
 
 
 
 
 
Figure 7.  Model of cytochrome c regulation. Under healthy conditions (left) Cytc allows 
efficient energy production through the mitochondrial pathway. Cancer signaling (right) leads to 
a change in its acetylation state causing an inhibition of respiration (“Warburg effect”), and it also 
renders Cytc incapable to trigger apoptosis allowing cancer cells to evade apoptosis. 
 
In vitro studies have shown that phosphorylation of Tyr-48 could operate as a toggle, fully 
inhibiting the capability of Cytc to trigger apoptosis (Pecina et al., 2010). Similar to 
phosphorylation, Lys acetylation results in a net increase of a negative charge, as a positive charge 
is lost upon acetylation. The net charge changes plus the position of Lys-53 which is located on 
the same domain of Cytc as Tyr-48, support our hypothesis that acetylation may also act as a switch 
for apoptosis in cancer cells. The previous results indicate that cellular respiration and apoptosis 
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are regulated by cell signaling via Cytc posttranslational modifications, and suggest a regulation 
of Cytc in cancer (Carver, 2014; Hüttemann et al., 2014). 
Considering the importance of Cytc in both respiration and apoptosis, it is still unknown 
how these functions are regulated in cancer. Therefore, the main goal of this study is to understand 
the regulation of mitochondrial respiration and apoptosis in cancer via regulation of Cytc. In order 
to test the hypothesis that acetylation of Cytc leads to inhibition of respiration and apoptosis, the 
acetyl-mimetic and control Cytc will be used as a model system to study Cytc function in vitro. 
 
2.2 Materials and Methods 
2.2.1. Generation of Cytochrome c Variants  
The bacterial expression plasmid pLW01 (gift from Dr. Lucy Waskell, University of 
Michigan), was used to generate Cytc variants and to overexpress them in the bacterial prokaryotic 
system. Bacteria do not have Cytc heme lyase (CYC3) (holo cytochrome c synthase), an enzyme 
catalyzing the attachment of heme to apo-cytochrome c, the pLWO1 plasmid contains the cDNA 
encoding CYC3 (Figure 8). Cytc mutants were expressed in Cytc double knock-out mouse lung 
fibroblasts (Vempati et al., 2007) using the mammalian expression plasmid, pBABE-puro (Catalog 
# 1764, Addgene, Cambridge, MA) (Figure 9).  
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Figure 8. pLWO1 expression vector. The bacterial expression plasmid pLW01 contains the 
cDNA encoding Cytc heme lyase (CYC3), an enzyme that covalently links the heme group to the 
apoprotein of Cytc. 
 
 
Figure 9. pBABE-puro expression vector. Mammalian expression plasmid containing the 
bacterial origin of replication, ampicillin-resistance gene, and puromycin-resistance gene for 
selection stable cell lines. The picture is taken from Addgene, Cambridge, MA, 
https://www.addgene.org/1764/ 
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Site-directed mutagenesis was applied to produce three Cytc variants. The cDNA of non-
acetylated wild type Cytc contains a lysine residue at position 53 which was mutated to the 
acetylmimetic glutamine, a non-acetylated arginine that carries a positive charge, and to the 
nonpolar isoleucine as an additional control. The QuickChange II Site-Directed Mutagenesis Kit 
(Catalog # 200523, Agilent Technology, CA) was used to introduce the desired mutations and to 
clone the mutated cDNA into pLWO1 and pBABE-puro expression vectors. The quick 
manufacturer's protocol (Figure 10) allows generating mutations with the efficiency higher than 
80%.  
 
Figure 10.  Overview of the QuickChange II site-directed mutagenesis method. The 
QuickChange II Site-Directed Mutagenesis Kit allows introducing a site-specific mutation in a 
double-stranded plasmid. The kit does not require unique restriction sites and multiple 
transformations. The picture is taken from Agilent Technology, CA 
http://www.genomics.agilent.com/article.jsp?pageId=384 
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For each Cytc variant, two synthetic oligonucleotide primers complementary to the 
opposite strand of the vectors were designed for use in thermocycling PCR (Table 2). During PCR, 
primer extension by PfuUltra high-fidelity DNA polymerase creates a mutated plasmid. The 
mutated plasmid is then digested for one hour at 37°C with Dpn I, a specific endonuclease which 
digests the parental methylated DNA, making it possible to isolate plasmids with the introduced 
mutations. The mutant plasmids were then transformed into the XL1-Blue competent cells and 
were plated on the agar plates with 100 µg/mL ampicillin. Plates were incubated overnight at 37°C.  
Next day, colonies were transferred to the cell-culture tubes with 5 mL of LB medium with 100 
µg/mL ampicillin and were grown overnight at 37 °C under constant shaking. All plasmids from 
overnight culture were puriﬁed using the QIAprep Spin Miniprep Kit (Catalog # 27106, Qiagen, 
Valencia, CA) following the manufacturer’s protocol. NanoDrop 1000 Spectrophotometer 
(Thermo Fisher Scientific, Waltham, MA) was used to quantify and assess the purity of DNA. The 
desired Cytc constructs were confirmed by sequencing. 
 
Table 2. Designed primers for the QuickChange II site-directed mutagenesis protocol 
Name Primer’s Sequences Tm (°C) 
Lys53Gln,  
Forward primer 
5' CTT ACA CAG ATG CCA ACC AGA ACA AAG GTA 
TCA CC 3' 
62.8 
Lys53Gln,  
Reverse primer 
5' GGT GAT ACC TTT GTT CTG GTT GGC ATC TGT GTA 
AG 3' 
62.8 
Lys53Arg, 
Forward primer 
5' CTT ACA CAG ATG CCA ACA GGA ACA AAG GTA 
TCA CC 3' 
62.8 
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Lys53Arg, 
Reverse primer 
5' GGT GAT ACC TTT GTT CCT GTT GGC ATC TGT GTA 
AG 3' 
62.8 
Lys53Ile, 
Forward primer 
5' CTT ACA CAG ATG CCA ACA TTA ACA AAG GTA 
TCA CCT G 3' 
61.4 
Lys53Ile, 
Reverse primer 
5' CAG GTG ATA CCT TTG TTA ATG TTG GCA TCT GTG 
TAA G 3' 
61.4 
 
2.2.2. Bacterial Overexpression of Cytochrome c Variants  
Sequence-confirmed PLWO1 constructs were used to transform competent C41(DE3) 
E.coli cells (Catalog # 60442-1, Lucigen, Middleton, WI) for protein overexpression and 
purification, using the heat shock method. Competent C41(DE3) cells were thawed on ice. DNA 
at a concentration of 50 ng was added to the competent cells. Culture tubes with a mixture 
containing cells and DNA were incubated on ice for 30 minutes and then placed in a 42°C water 
bath for 45 seconds (heat shock), followed by incubation on ice for 2 min. 950 µL of room 
temperature LB medium was added to the cells, and culture tubes were placed in a shaking 
incubator at 250 rpm for 1 hour at 37 °C. 200 µL of the transformation was plated on LB-agar 
plates containing 100 µg/mL ampicillin and incubated overnight at 37°C. Selected clones were 
inoculated into 10 mL of LB medium with 100 µg/mL ampicillin and were grown overnight at 37 
°C under constant shaking. The overnight culture was added into three flasks with 1L of TB 
medium (Difco, BD, Franklin Lakes, NJ) and 100 µg/mL of carbenicillin. The culture was grown 
until an OD600 of 1-1.5 was reached. At this point, 100 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG) was added to induce the expression of Cytc. The induced cultures were incubated for 6 h 
and, every 2 h, 1mL of culture was collected to check the expression by Western blotting. The 
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bacterial cells were pelleted by centrifugation at 4500 rpm, for 40 min at 4°C. The cell pellets were 
instantly frozen and stored at - 80 °C.  
 
2.2.3.  Western Blotting Analyses of the Overexpressed Cytochrome c 
Western blotting analyses were performed to analyze the bacterial overexpression of Cytc, 
with a 1:1000 dilution of mouse Anti-Cytochrome c primary antibodies (BD Pharmingen), 
followed by a 1:5000 dilution of Anti-mouse IgG, horseradish secondary antibody (GE 
Healthcare). Sigma cytochrome c was used as a control. The overexpression of Cytc was checked 
after 0, 2, 4, and 6 hours after IPTG induction. One mL of culture was collected at each time point 
and centrifuged for 5 min at max speed. The bacterial cell pellets were resuspended in lysis buffer 
(20 mM phosphate buffer, pH 7.4), supplemented with a protease inhibitor mixture (P8340) as 
recommended by the manufacturer. The concentration of cell lysate was determined by the DC 
Protein Assay (Catalog # 5000111, Bio-Rad, Hercules, CA) following the manufacturer’s protocol. 
Twenty µg of protein lysate were denatured at 95°C for 5 min after mixing with 4X loading buffer. 
The protein samples were separated using 12% SDS-PAGE and then transferred to PVDF 
membranes (0,2 um, Bio-Rad, Hercules, CA) using a semi-dry apparatus (Bio-Rad, Hercules, CA). 
The membrane was blocked with 5% non-fat dry milk for 1 hour, and then incubated with the 
primary antibody under shaking overnight at 4°C, followed by incubation with the respective 
secondary antibody for 2 h at room temperature. Each incubation was followed by washing the 
membrane with 1x TBS-T 6 times for 10 min. The signal was detected with HyGLO 
chemiluminescent HRP detection reagent (Catalog # E2500, Denville Scientific Inc, NJ) following 
the manufacturer’s protocol. 
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2.2.4. Purification of Cytochrome c Variants  
The bacterial cell pellets were thawed and resuspended in lysis buffer (20 mM phosphate 
buffer, pH 7.4), supplemented with a protease inhibitor mixture (P8340) as recommended by the 
manufacturer. For each 10 g of pellet, 100 mL of lysis buffer were used.  The cells afterward were 
lysed by a French Pressure Cell Press (AMINCO, American Instrument Co.). To remove cell 
debris, the cell lysates were centrifugated for 45 min at 15,000 rpm. The supernatant was adjusted 
to pH 7.5 and diluted with ddH2O until a conductivity of 4 mS/cm was reached and matched with 
the DE52 anion-exchange column (Whatman, Piscataway, NJ). Adjusted supernatant was applied 
to the equilibrated DE column. Most of the bacterial proteins were bound to the column and Cytc 
was collected within the flow-through. The collected solution was adjusted to pH 6.5 and 
conductivity was increased by addition of KH2PO4 buffer until it reached 6 mS/cm and matched 
with the CM52 cellulose cation-exchange column (Whatman, Piscataway, NJ). The adjusted flow-
through was applied to the previously equilibrated CM column with 40 mM phosphate buffer, pH 
6.5, allowing the positively charged Cytc to bind to the CM column. After washing the CM 
column, the bound Cytc was eluted with high salt buffer (0.5 M NaCl in 40 mM phosphate buffer, 
pH 6.5). Cytc fractions were desalted and concentrated by centrifugation using Amicon Ultra-15 
3k units (Catalog # UFC901008, Millipore, Billerica, MA). Cytc was aliquoted and stored in -
80°C. The workflow of the expression and purification of Cytc variants is presented in Figure 11.   
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Figure 11. Expression and purification of cytochrome c variants. Flowchart of recombinant 
protein expression and purification via two steps ion exchange chromatography. 
 
2.2.5. Analysis of Cytochrome c Absorption Spectra 
 100 µM of Cytc mutants were oxidized with a few granules of K3Fe(CN)6 and desalted 
with NAP-5 columns (Catalog # 17-0853-02, GE Healthcare, Piscataway, NJ). Absorption spectra 
were recorded on a Jasco V-570 double beam spectrophotometer (2 nm bandwidth, 200 nm/min 
scanning speed). Reduced Cytc was obtained by adding a few granules of sodium dithionite, 
removing reductant via NAP-5 columns, and acquiring spectra as described above (Pecina et al., 
2010). 
 
2.2.6. Determination of the Concentration of Cytochrome c Variants  
Purified Cytc variants (WT, Lys53Arg, Lys53Gln, and Lys53Ile) were reduced with a few 
granules of sodium dithionite and desalted with NAP-5 columns (Catalog # 17-0853-02, GE 
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Healthcare, Piscataway, NJ). Absorption spectra at 550 nm for each mutant were recorded on a 
Jasco V-570 double beam spectrophotometer (2 nm bandwidth, 200 nm/min scanning speed) using 
a 0.1-mm path length quartz cuvette. Afterwards, Cytc mutants were oxidized with a few granules 
of K3Fe(CN)6 and desalted with NAP-5 columns. The acquisition of absorption spectra at 550 nm 
were recorded as described above. The concentration of Cyc variants were defined by differential 
spectra at 550 nm by subtracting the oxidized form from the reduced form and calculated via Cytc 
(mM) = Ab550red-Ab550ox/19.6 x dilution factor.  
 
2.2.7. Mass Spectrometry of Castrate-Resistant and Castrate-Sensitive Prostate Tumor 
Xenografts to Detect Site-Specific Acetylation  
 Castrate-resistant (PC3) and castrate-sensitive (VCaP) prostate cancer cells were implanted 
into SCID mice at the Animal Model and Therapeutics Evaluation Core under Dr. Polin. Tumors 
were harvested and Cytc was purified by immunoprecipitation and analyzed by mass spectrometry. 
Peptides were injected into the mass spectrometer (LTQ Orbitrap-Velos, Thermo Scientific, 
Waltham, MA) after electrospray ionization. MS/MS spectra were obtained in positive ion mode, 
assigned to peptide sequences from the UniProt protein database, searched with the MASCOT 
algorithm for PTMs, and manually verified. 
 
2.2.8. Caspase- 3 Activity Induction by Cytochrome c Variants 
 The ability of purified Cytochrome c variants to induce caspase-3 activation was assayed 
in vitro with cytoplasmic extracts prepared from cultured HeLa cells, previously described (Slee 
et al., 1999). After trypsinization, cells from 8 x 75 cm2 flasks were pelleted by 4°C centrifugation 
at and washed twice with 1x PBS, followed by washing with ice-cold cell extraction buffer (CEB: 
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20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1mM EGTA, 1 mM 
dithiothreitol, 100 µM PMSF). The pellet was gently resuspended in two volumes of CEB and 
transferred to an ice-cold Dounce homogenizer. Cells were disrupted by 20 strokes with a B-type 
glass pestle after 15 min of swelling on ice. Cell breakage was confirmed using a microscope. The 
lysates were transferred to microcentrifuge tubes and centrifuged at 15,000g for 15 min at 4°C to 
remove nuclei and debris. The protein concentration of the supernatant, containing cytosolic 
fraction, was determined by DC Protein Assay (Catalog # 5000111, Bio-Rad, Hercules, CA). The 
EnzChek Caspase-3 Assay Kit # 2 (Catalog # E13184, Invitrogen, Carlsbad, CA) with the 
rhodamine 110-linked DEVD tetrapeptide, an artificial substrate for caspase-3 that fluoresces upon 
caspase-3 cleavage, was used to measure Caspase-3 activity. Cytosolic extracts at a concentration 
of 2 mg/mL were incubated with 15 µg/mL of Cytc variants for 2.5 h at 37 °C. Aliquots of 10 µL 
of activated extracts after incubation were assayed for caspase-3 activity in triplicates. The same 
aliquots were used for the triplicates containing a caspase-3 inhibitor in parallel. A Fluoroskan 
Ascent FL plate reader (Labsystems, Thermo Scientific, Waltham, MA) was used to detect 
fluorescence from the cleavage of the artificial caspase-3 substrate over 3 h in 30-min intervals, 
using excitation filter 485 nm/14 nm bandwidth, and emission filter 527 nm/bandwidth 10 nm. 
The amount of cleaved caspase-3 substrate was calculated from the rhodamine 110 calibration 
curve. Data values are expressed in % fluorescence of WT. The signal from caspase-3 inhibitor 
wells was subtracted from the results, as a background (Pecina et al., 2010). 
 
2.2.9. Cytochrome c Oxidase Activity Measurements 
 Previously isolated regulatory-competent bovine liver COX was used for this experiment 
(Lee et al., 2009). A COX aliquot was diluted to the final concentration of 3 µM in the presence 
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of a 40-fold molar express of cardiolipin and 0.1 mM ATP in COX measuring buffer (10 mM K-
HEPES (pH 7.4), 40 mM KCl, 2 mM EGTA, 10 mMKF, 1% Tween 20). To remove cholate bound 
to COX during enzyme purification, the diluted aliquot of COX was dialyzed overnight at 4°C. 
Respiration of COX (150 nM) was analyzed in a closed chamber equipped with a micro-Clark-
type oxygen electrode (Oxygraph system, Hansatech, Pentney, UK) (Figure 12) at 25°C in 220 µL 
of COX measuring buffer and 20 mM ascorbate as electron donor. Increasing amounts of purified 
Cytc mutants (0-25 µM) were added, and oxygen consumption was recorded and analyzed with 
the Oxygraph software (Hansatech). The activity of COX was expressed as turnover number (TN) 
(s-1) (Mahapatra et al., 2017). 
 
Figure 12. Hansatech Oxygraph Plus System connected to a water bath. Liquid-phase 
respiration measurement system. PC displays results real-time (0 to 4.5v analog output of oxygen 
electrode signal). 
 
2.2.10. Measurement of Cytochrome c Redox Potential 
 The midpoint redox potential (E0’) was analyzed spectrophotometrically by the 
equilibration method described (Cammack, 1995) using 2,6dichloroindophenol (DCIP, E0’=237 
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mV) as a reference compound, which has an absorption band at 600 nm in its oxidized state. One 
hundred μL of Cytc solution (2 mg/mL) was mixed in a spectrophotometric cuvette with 200 μL 
of 50 mM citrate buffer, pH 6.5, 10 μL of 1 mM DCIP, and 2.5 μL of 1 mM K3Fe(CN)6 to fully 
oxidize Cytc. Absorbance values corresponding to fully oxidized Cytc (A550-A570) and DCIP (A600) 
were recorded using a Jasco V-570 double beam spectrophotometer. The mixture was then 
sequentially reduced by adding 0.5 μL of 1 mM ascorbate (pH 6.5), and absorbance values were 
acquired at each step. When readings became constant, a few grains of sodium dithionite 
(Na2S2O4) were added to fully reduce Cytc and DCIP. For each step, ratios of oxidized and reduced 
forms of both compounds were calculated. Data obtained were plotted as log(DCIPOX/DCIPRED) 
versus log(CytOX/CytRED), yielding a linear graph with a slope of n-DCIP/n-Cytc and a y-axis 
intercept of n-Cytc / 59.2 (E Cytc – E DCIP). These values were used to calculate the E0’ (mV) of 
Cytc from the Nernst equation (Pecina et al., 2010). 
 
2.2.11. Measurement of Rates of Oxidation and Reduction   
 The kinetics of oxidation of 15 µM ferro-Cytc variants with 50 µM H2O2 and reduction 
of 15 µM ferri-Cytc variants with 200 µM ascorbate were measured spectrophotometrically at 550 
nm as described (Liu et al., 2006). Cytc mutants were reduced with sodium dithionite, and the 
proteins were separated from the reductant through NAP-5 columns (Catalog # 17-0853-02, GE 
Healthcare, Piscataway, NJ). Fifteen µM Cytc in 0.2 M Tris-Cl, pH 7.0 were incubated with 50 
µM oxidizing agent H2O2 and after 10 sec, the decrease of the absorption peak at 550 nm was 
measured, and the amount of oxidized Cytc was calculated as described above. To measure the 
kinetics of reduction of Cytc with ascorbate, Cytc variants were fully oxidized with K3Fe(CN)6 
and purified using NAP-5 columns. Fifteen µM ferri-Cytc were added to 50 mM sodium 
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phosphate, 25 mM sodium dithionite (Na2SO4), pH 7.0 and 200 µM ascorbate to a cuvette, which 
was then sealed from air, and the initial rate of reduction was measured at 550 nm (Mahapatra et 
al., 2017). 
 
2.2.12. Measurement of Peroxidase Activity of Cytochrome c Mutants 
 Peroxidase activity of WT Cytc variants were analyzed by their efficiency in the oxidation 
of a prototypical phenolic substrate, Amplex Red, to its product, resorufin as previously described 
by (Pecina et al., 2010). Cytc variants with the concentration of 1 µM were incubated with 
liposomes containing TOCL/1,2-dioleoyl-sn-glycero-3-phospocholine in a 1:1 ratio for 10 min. 
By the addition of Amplex Red (50 µM) and H2O2 (50 µM) the peroxidase reaction was started 
and was carried out for 20 min, while the rate of the reaction become linear. Fluorescence was 
detected by employing a “Fusion R” universal microplate analyzer by using an excitation 
wavelength of 535 nm and an emission wavelength of 585 nm (Mahapatra et al., 2017).  
 
2.2.13. Crystallization of Cytochrome c Variants  
Before crystallization, Cytc was purified with DE52 and CM52 columns (Whatman, 
Piscataway, NJ). The proteins were concentrated by using Amicon Ultra-15 3k units (Catalog # 
UFC901008, Millipore, Billerica, MA), and buffer exchange with deionized water. The proteins 
were oxidized with 5 mM potassium ferricyanide to establish a defined oxidation state just before 
the crystallization. Crystallization was done by using Jena Biosciences basic screens. Protein 
concentration was approximately 15-20 mg/ml. Crystals were grown by vapor diffusion after 
mixing 1 µL of protein solution with 1 µL of the reservoir solution and equilibrating the drop 
against 0.5 mL of the precipitant at room temperature. Crystals were soaked for 10 min in a cryo-
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protectant solution (20% v/v ethylene glycol) before flash freezing in liquid nitrogen. Single 
crystal diffraction data were collected at the Life Sciences Collaborative Access Team facility 
(Advanced Photon Source sector 21, Argonne National Laboratory). The data were collected over 
a full 360° rotation in either 0.6 or 1.0° frames and integrated using XDS (Kabsch, 2010) in Auto-
Proc (Vonrhein et al., 2011).  
 
2.2.14. Cell Culture 
 Mouse lung fibroblasts in which both the somatic and testes-specific Cytc isoforms have 
been knocked out, were cultured in high glucose Gibco Dulbecco's Modified Eagle Medium 
(Catalog # 11965-092, Thermo Fisher Scientific, Waltham, MA) supplemented with 1 mM sodium 
pyruvate, 50 µg/mL uridine, 10% fetal bovine serum with 1% penicillin-streptomycin at 37°C and 
5% CO2 (Mahapatra et al., 2017). Double knockout of Cytc is required because cultured mouse 
cells lacking somatic Cytc induce the expression of the testes isoform, restoring mitochondrial 
respiration (Vempati et al., 2007). 
  
2.2.15. Transient Transfection and Selection of Double Knockout Mouse Lung Fibroblasts  
The pBABE expression plasmid (Catalog # 1764, Addgene, Cambridge, MA) was used for 
the expression of Cytc variants in mammalian cells. The double knockout mouse lung fibroblasts 
were transfected with the empty vector (EV) control, the WT Cytc, and mutant constructs using 
TransFast transfection reagent (Catalog # E2431, Promega, Madison, WI) following the 
manufacturer’s protocol. Cells were plated onto 100 mm culture dishes at a concentration of 1.3 x 
106 cells per dish a day before transfection. On the day of transfection, the TransFast reagent was 
mixed with the 10 µg of DNA at a ratio of 1:1 in serum- and antibiotic-free medium. Following 
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incubation at room temperature for 15 min, the mixture was overlaid onto the cells. The plates 
were incubated for 2 h at 37°C, and the cells were transferred to complete medium for 72 h and 
incubated at 37°C. Stable cell lines expressing WT, three Cytc variants, and an empty vector 
control were selected in the presence of 1.5 µg/mL puromycin.  
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CHAPTER 3 
RESULTS 
 
3.1 Cytochrome c is Acetylated on Lys53 in Prostate Cancer Xenografts  
Mass spectrometry unambiguously revealed that Cytc is acetylated on Lys-53 in both 
castrate-resistant (PC3) and castrate-sensitive (VCaP) tumors (Figure 13). Human Cytc has 18 
lysine residues; however, only Lys-53 residue contained an acetyl group in all 8-independent 
castrate-resistant and -sensitive prostate cancer xenografts (4 each). It is suggested that this is a 
cancer-specific modification. Importantly, phosphorylations, which are present in healthy tissues, 
were not detected in any of the tumor xenografts, indicating a dichotomy between signaling in 
normal and transformed cells that target Cytc.  
 
Figure 13. Nano-LC/ESI/MS/MS spectrum of TGQAPGYSYTAANKNK. Mass spectrum of 
Cytc peptide TGQAPGYSYTAANK(acetyl)NK identifying Cytc Lys-53 acetylation (underlined). 
For instance, one spectrum is shown from one castrate sensitive tumor xenograft. The acetyl 
moiety was unambiguously assigned to this lysine via fragment ions y4+, y5+ etc. and b14+ 
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containing 42 extra mass units for the acetyl group. The peptide sequence was unambiguously 
revealed by fragment ions b3
+, b4
+, b11
+, y4
+, y5
+, y7
+, y8
+, y9
+, y10
+, y11
+, y12
+, y12
2+, and y13
+. 
 
Additionally, Lys-53 is conserved in mammals (Zaidi et al., 2014) which points to a central 
regulatory site. The epitope surrounding Lys-53 was aligned with the Clustal Omega program 
(Figure 14) to visualize the conserved residue. Figure 15 shows the ribbon model of Cytc with 
Lys-53 residue highlighted. 
 
Figure 14. Cytc sequence alignment reveals that Lys-53 is conserved in mammals. The Clustal 
Omega program was used to align Cytc sequences. Lys-53 (bolded red and underlined) is 
conserved in all mammalian analyzed species. Identical amino acids are indicated with an asterisk. 
 
Figure 15. Ribbon model of cytochrome c. The heme group is shown in dark red. The Lys-53 
residue is shown in yellow. 
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3.2 Sequence Confirmation of Cytochrome c mutants 
To purify sufficient amounts of acetylated Cytc in vivo for functional studies we would 
need about 500 g of prostate cancer tissue. Since the above method via tumor xenografts is cost-
prohibitive, we applied a genetic approach instead. The effective and commonly used method to 
study the effects of protein acetylation in vitro is acetyl-mimetic substitution of an amino acid, i.e., 
replacement of the lysine with a glutamine residue. The acetyl-mimetic mutant mimics constitutive 
acetylation, converts the positive charge of the lysine to a neutral charge, similar to the effect of 
acetylation of a lysine residue that often results in functional changes like that seen with the 
acetylated protein in vivo. The bacterial pLWO1 and mammalian pBABE plasmids were used to 
generate WT Cytc, acetyl-mimetic Lys53Gln, Lys53Arg (carries a positive charge, similar to non-
acetylated lysine), and Lys53IIe (nonpolar/hydrophobic) as an additional control. The desired 
pLWO1 (Figure 16) and pBABE (Figure 17) Cytc constructs were confirmed by sequencing. In 
the pLWO1 constructs there is only one single desired mutation of the Lys-53 residue. In the 
pBABE constructs there are two additional silent mutations which do not result in a change to the 
amino acid sequence of the protein.   
 
 
 
 
 
48 
 
 
 
 
 
Figure 16. Sequence confirmation of pLWO1 cytochrome c constructs. The circled codons 
indicate the introduction of desired mutations on pLWO1 WT Cytc. Cytc Lys-53 was mutated to 
the Lys53Gln (acetylmimetic glutamine), Lys53Arg (cannot be acetylated), and Lys53Ile 
(nonpolar, as an additional control). 
 
 
 
Figure 17. Sequence confirmation of pBABE cytochrome c constructs. The circled codons 
indicate the introduction of desired mutations on pBABE WT Cytc. Cytc Lys-53 was mutated to 
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the Lys53Gln (acetylmimetic glutamine), Lys53Arg (cannot be acetylated), and Lys53Ile 
(nonpolar, as an additional control). 
 
3.3 Transient Transfection of Double Knockout Mouse Lung Fibroblasts 
 Double knockout mouse lung fibroblasts in which both the somatic and testes-specific Cytc 
isoforms have been knocked out, were confirmed by Western blot (Figure 18, KOLF). The absence 
of the band at 12 kD, and the presence of GAPDH loading control at 35 kD indicates that the cells 
are knocked out. The pBABE expression plasmid was used for the expression of Cytc variants in 
mammalian cells. The WT Cytc and mutant constructs were transfected into Cytc double knockout 
mouse lung fibroblasts. Cell lines expressing the three Cytc variants and an empty vector control 
were selected in the presence of 1.5 µg/mL puromycin.  
 
Figure 18. Western blot analysis of the double knockout mouse lung fibroblasts. Line 1-2, 
Cytc-/- mouse lung fibroblasts (KOLF) cell lysates 100 and 75 ng/µl; Line 3-4, cow heart Cytc 
100 and 75 ng/µl respectively (Sigma, Western positive control).   
 
3.4 Cytochrome c Variants were Overexpressed in E. coli 
 pLWO1 constructs confirmed by sequencing were used to transform competent E. coli C41 
cells for protein overexpression and further purification by ion exchange chromatography. IPTG 
was used to induce the expression of Cytc. To check the protein expression level, 1 mL of culture 
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sample was harvested every 2 h. After 6 h induction, the small bacterial pellets showed a rich pink 
color (Figure 19), suggesting the presence of Cytc protein.  
 
Figure 19. Overexpression of Lys53Gln cytochrome c after 0, 2, 4, and 6 hours IPTG 
induction. With the increase of IPTG induction hours, bacterial pellets acquire pink color, 
indicating the overexpression of Cytc in E. coli. 
 
Samples with 2, 4, and 6 h of induction were analyzed by Western Blotting with Sigma 
Cytc as positive control, and Cytc-/- cell lysates as a negative control (Figure 20). Bands at 12 kDa 
indicate the overexpressed Cytc, and bands at 35 kDa indicate the GAPDH loading control for 
Cytc-/- cell lysates. IPTG induction was stopped after 6 h. The large culture was centrifuged and 
the pink pellet (Figure 21) was stored at -80°C for further experiments.  
 
Figure 20. Western blot analysis of the overexpressed Lys53Gln cytochrome c after 2, 4, and 
6 hours of IPTG induction. Lane 1, cow heart Cytc (Sigma); lane 2, Lys53Gln Cytc after 2h 
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IPTG induction; lane 3, Lys53Gln Cytc after 4h IPTG induction; lane 4, Lys53Gln Cytc after 6h 
IPTG induction; lane 5, Cytc-/- cell lysates (Western negative control). 
 
 
Figure 21. Bacterial pellets of the overexpressed Lys53Gln cytochrome c. Bacterial pellets 
from a large culture showed a rich pink color after 6 hours of IPTG induction.  
 
3.5 Concentration Determination and Purification of Functional and Correctly Folded 
Cytochrome c Variants from Escherichia coli 
 Overexpressed WT, Lys53Gln, Lys53Arg, and Lys53Ile Cytc were purified in a two-step 
ion-exchange chromatography with DE52 anion-exchange and CM52 cellulose cation-exchange 
columns. After protein concentration, the yields of proteins vary from 15 - 25 mg/mL. The purity 
of proteins was analyzed spectrophotometrically, with 410 nm/280 nm rations > 4 as an indicator 
and marker value of Cytc purity (Patel et al., 2001). The WT Cytc and all three mutants were fully 
reducible according to the absorption spectra measurements (Figure 22). Additionally, the 
presence of the weak 695 nm absorption peak in the oxidized state of Cytc variants suggest that 
all mutant and WT proteins were purified in the correctly folded conformation (state III) (Figure 
22, insert). This peak is caused by the interaction between Met-80 and the heme iron. It called as 
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an “indicator of trouble” since it is usually lost after any harmful treatment, which leads to 
denaturation of Cytc (Dickerson and Timkovich, 1975). 
 
Figure 22. Purified cytochrome c mutant’s absorption spectra. One hundred µM of WT, 
Lys53Arg, Lys53Gln, and Lys53Ile overexpressed proteins were oxidized with K3Fe(CN)6 and 
desalted via NAP-5 columns. Absorption spectra were recorded on a Jasco V-570 double beam 
spectrophotometer (2 nm bandwidth, 200 nm/min scanning speed). Reduced Cytc proteins were 
obtained by adding few granules of sodium dithionite. Insert: The weak 695 nm absorption band 
of oxidized Cytc. 
 
3.6 Acetylmimetic Lys53Gln Cytochrome c Mutant Exhibits a Decrease in Respiration Rate 
with Isolated Cytochrome c Oxidase  
The hallmarks of cancer growth are increased glycolysis and lactate production. 
Malignancies and tumor cell expansion are also characterized by mitochondrial respiration deficits 
and depletion of OXPHOS. Therefore, we proposed that acetylation state of Cytc triggers an 
inhibition of mitochondrial respiration and causes the metabolic switch, the Warburg effect. To 
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test the hypothesis that Cytc acetylation leads to inhibition of respiration, we analyzed the activity 
of purified COX with purified Cytc variants as substrates. COX was previously isolated from 
bovine liver under conditions that preserve phosphorylation status in vivo and yield a regulatory 
competent enzyme (Lee et al., 2009). Oxygen consumption of 0.15 µM bovine liver COX was 
measured using a Clark type oxygen electrode system at 25°C with titrations (1-25 µM) of purified 
Cyc variants. The experimental results demonstrated that COX oxidizes acetylmimetic Lys53Gln 
and nonpolar Lys53Ile Cytc mutants at lower rates compared to the WT Cytc and Lys53Arg 
control mutant (Figure 23). The kinetics of Cytc oxidation by COX revealed that maximal velocity 
of acetylated Cytc reduced by approximately 50% compared to the WT.  The data suggest that 
acetylation of Cytc down-regulates mitochondrial ETC electron flux and leads to inhibition of 
respiration. These results could also deepen the understanding of the molecular pathways leading 
to mitochondrial inhibition and metabolic switching during tumorigenesis, i.e., Warburg 
metabolism. 
 
Figure 23. Measurements of Cytochrome c oxidase activity with purified cytochrome c 
mutants. Vmax of acetylmimetic Lys53 mutant decreased by approximately 50% with the 
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comparison to the WT Cytc. Data is expressed as turnover number (sec-1). Shown are 
representative measurements (n=3). 
 
3.7 Acetylmimetic Lys53Gln Cytochrome c is Incapable to Activate Caspase-3 and Turns 
off Apoptosis 
 Apoptosis is a mechanism by which damaged cells are programmed to cell death and to 
commit suicide. Cancer cells manage to bypass this mechanism and are able to evade apoptosis. 
Considering the crucial role of Cytc in programmed cell death, we hypothesized that acetylation 
of Cytc could lead to inhibition of apoptosis in cancer cells. To test the hypothesis, we analyzed 
the ability of Cytc variants to initiate the programmed cell death by downstream activation of 
Caspase-3. 15 µg/mL of purified WT Cytc, Lys53Gln, Lys53Arg, and Lys53Ile mutants were 
incubated with 2 mg/mL of cytosolic extract from HeLa cells for 2.5 hours at 37°C. The activity 
of caspase-3 was measured by following cleavage of the artificial substrate DEVD coupled to 
fluorescent rhodamine. Interestingly, the results indicated that acetylmimetic Lys53Gln and 
nonpolar Lys53Ile Cytc mutants were unable to trigger caspase-3 activity and induce apoptosis, 
compared to WT. Interestingly, the Lys53Arg Cytc control mutant demonstrated higher activity of 
caspase-3 activation and ability to execute apoptosis than WT Cytc (Figure 24). Our data suggests 
that acetylation of Cytc affects protein function at the apoptosome formation level, and 
modification of the key regulatory epitope of Cytc turns off the programmed cell death. This result 
could potentially establish the mechanisms underlying evasion of apoptosis in prostate cancer. 
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Figure 24. The ability to trigger downstream caspase-3 activation is strongly inhibited in 
cytochrome c acetylmimetic Lys53Gln and nonpolar control Lys53Ile mutants in vitro. 
Cleavage of the artificial caspase-3 substrate DEVD-R110 via induced caspase-3 was measured in 
10 µL aliquots of preincubated Cytc variants and HeLa cell cytosolic fractions (n=3).   
 
3.8 Assessments of Peroxidase Activity of Cytochrome c Mutants 
Cytc plays role in cardiolipin peroxidation. Cytc binds to cardiolipin and this interaction 
causes partial unfolding of the enzyme, as well as making the bond between the heme group and 
Met-80 weaker, unleashing its peroxidase activity. Peroxidation of cardiolipin and other lipids 
leads to damage of the mitochondrial membrane, which enhances the release of Cytc from the 
mitochondria during apoptosis.  
Peroxidase activity of the Cytc variants was analyzed by their efficiency to oxidize 
cardiolipin (CL) reconstituted in vesicles, which after oxidation oxidizes a prototypical phenolic 
substrate, Amplex Red, to its product, resorufin. Thus, assessment of peroxidase activity with 
Amplex Red was performed by measuring the fluorescence of resorufin, an oxidation product of 
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Amplex Red. 1 μM of Cytc was incubated with liposomes containing TOCL/DOPC at a ratio 1:1 
for 10 min. The peroxidase reaction was started by the addition of 50 μM Amplex Red and 50 μM 
H2O2 and was carried out for 20 min (reaction rate was linear during the entire time interval). 
Fluorescence was detected by employing a “Fusion R” universal microplate analyzer and by using 
an excitation wavelength of 535 nm and an emission wavelength of 590 nm. The data showed that 
the peroxidase activity of the acetylmimetic Lys53Gln and nonpolar Lys53Ile Cytc mutants were 
slightly lower than that of the WT Cytc. Interestingly, the peroxidase activity of Lys53Arg Cytc 
mutant was higher than the activity of the WT, suggesting that it unfolds more easily than WT and 
the Lys53Gln and Lys53Ile mutants (Figure 25). These findings align with the apoptotic assay 
results. The Lys53Arg Cytc mutant demonstrated the highest ability to activate caspase-3 and 
induce apoptosis, while acetylmimetic Lys53Gln and nonpolar Lys53Ile were incapable of 
triggering apoptosis.  
 
Figure 25. Peroxidase activity of the cytochrome c variants.  Assessment of peroxidase 
activity with Amplex Red reagent was performed by measuring the fluorescence of resorufin, an 
oxidation product of Amplex Red. 
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3.9 Measurement of Redox Potential of Cytochrome c Mutants 
 Cytc is an electron carrier between complex III and complex IV in the ETC. For the proper 
protein function, Cytc redox potential should be in the range between the redox potential of 
complexes III and IV. The literature values of mammalian Cytc redox potential are in the range of 
220-270 mV (Cammack, 1995; Nicholls and Ferguson, 1992). The enzyme midpoint redox 
potential (E0’) of purified Cytc variants was measured spectrophotometrically via the equilibration 
method using DCIP as substrate. The average redox potential of WT Cytc was 256 mV which is 
similar to the literature value. Cytc mutant’s values were 254 for Lys53Gln, 250 for Lys53Arg, 
and 261 for Lys53Ile, which are in range between the redox potential of complex III and IV (Figure 
26). The results suggest the thermodynamic feasibility of Cytc mutant's proper function within the 
respiratory chain. 
 
Figure 26. Measurement of cytochrome c mutant’s redox potential. Data were plotted as log 
(DCIPox/DCIPred) versus log(Cytox/Cytred) yielding a linear graph and Redox potentials were 
calculated using the Nernst equation from the intercept and slope of the graph. Final redox potential 
values are shown (n=5). 
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3.10 Measurement of Rates of Oxidation and Reduction of Cytochrome c Mutants 
 As described above, Cytc is able to function as a radical scavenger within the mitochondrial 
inner-membrane space.  The reduction of Cytc by superoxide, or oxidation of Cytc by H2O2 can 
regenerate the molecule of oxygen by removing electrons. Considering the antioxidant role of 
Cytc, we tested the ability of Cytc variants in the reaction with H2O2 and with the reductant 
ascorbate.  
To determine the rate of Cytc oxidation, Cytc variants were reduced with sodium dithionite, 
followed by removal of reductant via NAP-5 columns. The ferro-(Fe2+)-Cytc variants were 
oxidized in the presence of 50 µM H2O2. The Lys53Gln acetylmimetic mutant was oxidized at 
about twice the rate compared to WT and Lys53Arg Cytc controls, while the Lys53Ile mutant 
showed a 2.83-fold higher rate (Figure 27).  
 
Figure 27. Cytochrome c variants’ oxidation rate. The oxidation rate of the Lys53Gln and 
Lys53Ile Cytc mutants were increased approximately two - and threefold, respectively, 
compared to WT and Lys53Arg Cytc in the presence of H2O2 (n=7).  
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The reduction rate of Cytc variants was determined with the reductant ascorbate. Cytc 
variants were oxidized with K3Fe(CN)6 and desalted with NAP-5 columns. Ferri-(Fe3
+)-Cytc 
mutants were then reduced with 200 µM ascorbate. The acetylmimetic Lys53Gln and nonpolar 
Lys53Ile mutants were reduced at a much faster rate compared to WT and Lys53Arg Cytc controls 
(Figure 28). Taken together, our data suggest that the acetylmimetic Cytc can act as a good single 
electron donor and acceptor, thus, effectively scavenging ROS, which could be a selective 
advantage with acetylated Cytc for cancer cells which often face a high ROS load.  
 
Figure 28. Cytochrome c variants’ reduction rate. The reduction rate of Lys53Gln and 
Lys53Ile Cytc mutants were increased compared to WT and Lys53Arg Cytc in the presence of 
ascorbate (n=7).   
 
3.11 Crystallization of Cytochrome c Variants  
The best diffracting crystals of Lys53Gln mutant (Figure 29) grew to 0.3x.1mm size in 
plates in JBS1D4 condition which was 30% PEG 2K MME, 0.1M MES 6.5 and 0.1M Na-acetate. 
Figure 30 shows the components in the crystal structure of the Lys53Gln mutant that are within 
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3.5 Å of Gln53 in molecules A and B. The electron density from an unbiased “omit” map is shown 
at 1.0 sigma. The electron density for Gln-53 in molecule B is better defined because its side chain 
is immobilized by a hydrogen bond to the carbonyl oxygen of Tyr-40. The side chain of Gln-53 in 
molecule A interacts only with a water molecule within 3.5 Å. 
 
Figure 29. Crystal of the Lys53Gln cytochrome c mutant. 
 
 
 
Figure 30. The comparison of the “omit” density for the Lys53Gln in the two cytochrome c 
molecules in the asymmetric unit of the crystal structure. 
61 
 
 
 
The crystal structure of the Lys53Gln Cytc (blue) was superposed onto the structure of the 
native (5C0Z.pdb) cytochrome c (green) using only the A-chains in both structures (Figure 31). 
The four independent chains in the native structure are labeled with lower case letters. The two 
independent chains in the Lys53Gln Cytc structure are labeled with capital letters. The RMSD 
value for the superposed A-chains was 0.35 Å calculated from the backbone atoms. The protein 
structures are depicted as Cα traces with the atoms in the hemes and the ferrihexacyanide 
molecules represented by spheres. Panel A shows the front face of the 5C0Z tetramer in the P1 
asymmetric unit. Panel B shows the edge of the tetramer after a 90° rotation about the vertical axis. 
When the two structures are superposed using only the A-chains, the B-chain in the Lys53Gln 
Cytc structure partially overlaps with the D-chain in 5C0Z but their relative orientation in the two 
crystal structures differs dramatically (RMSD = 20.3 Å). The crystallographic parameters for the 
Lys53Gln structure are compared to those of the native mouse Cytc (5C0Z.pdb) and the Y47F 
human Cytc (3ZOO.pdb) structures in Table 3 below. 
 
Figure 31. The structure of Lys53Gln cytochrome c is superposed onto the native mouse/rat 
cytochrome c (5C0Z.pdb) using chain-A in both structures. The structure of Lys53Gln 
cytochrome c shown in blue, and native mouse/rat cytochrome c (5C0Z.pdb) shown in green.  
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Table 3. Crystallographic data summarizing and comparing three structures of mouse / rat 
cytochrome c: Native, K53Q, and human Y46F. 
STRUCTURE 
CYTC 
MOUSE 
CYTC (K53Q) 
MOUSE 
CYTC (Y47F) 
HUMAN 
PDB CODE 5C0Z N/A 3ZOO 
DATA CODE 141118x21a 161109x06a  
CRYSTALLIZATION    
Iron Oxidized Oxidized Oxidized 
Protein 
15 mg/mL Cytc 
(WT) + 5mM 
K3Fe(CN)6 in 
water 
17mg/mL Cytc 
(K53Q) + 5mM 
K3Fe(CN)6 in water 
12.5 mg/ml oxidized 
Cytc in 22.5% (w/v) 
PEG-1000, 50 mM 
KH2PO4, pH 7.0 
Well 
25% PEG 4K, 8% 
iso propanol, 
0.1M Na Acetate, 
pH 6.5 
30% PEG 2K MME, 
0.1M Na MES, 
0.1M Na Acetate, 
pH 6.5 
26-31% (W/V) PEG 
1000, 40 mM, KH2PO4. 
pH 7.0               
Drop 1:1 Protein:Well 1:1 Protein:Well n/a 
Cryoprotectant 
30% PEG 4K, 8% 
isopropanol, 
0.1M Na Acetate, 
20% Ethylene 
glycol, 10 min 
soak with  5mM 
35% PEG 2K MME, 
0.1M Na MES, 
0.1M Na Acetate, 
pH 6.5, 20% 
Ethylene glycol 
26-31% (w/v) PEG 
1000, 40 mM, KH2PO4, 
15% Glycerol, pH 7.0 
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K3Fe(CN)6, final 
ph 6.5 
CRYSTAL DATA    
Space group: P1 P2(1)2(1)2 P1 
Unit cell: a 34.401 53.055 36.367 
b 52.471 96.911 53.952 
c 61.647 38.072  58.95 
Alpha 110.04 90 76.55 
Beta 92.77 90 88.73 
Gamma 92.02 90 71.86 
Chains per A.U. 4 2 4 
Matthews Coeff 2.24 2.10 2.3 
Solvent % 45.12 41.4 46.7 
X-RAY DATA     
Resolution-high (Å) 1.12 1.31 1.35 
Resolution-low (Å) 49.22 48.38 30.59 
Beamline  APS 21-ID-F  APS 21-ID-D DIAMOND 103 (UK) 
Wavelength 0.97872 1.07822 0.9762 
Reflections 127840 48257 81707 
Completeness 87.4 (44.7) 98.9 (86.8) 94.7 (80.7) 
Average I/sigma 14.4 (2.0) 12.2 (2.1) 8.70 (n/a) 
Redundancy 3.9 (3.7) 11.1 (6.6) n/a 
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Rmerge 0.050 (0.548) 0.120 (0.821) 0.07 
REFINEMENT    
Rfactor  0.132 (0.239) 0.146 (0.352) 0.138 
Rfree 0.159 (0.240) 0.181 (0.364) 0.179 
Avg B-factor (Å2) 15.97 21.19 17.703 
Protein atoms per A.U. 3228 1917 3981 
Water molecules 537 388 417 
Bond RMSD 0.017 0.021 0.017 
Angle RMSD 1.903 2.372 1.99 
FC6 OCCUPANCY    
202a/A 0.28 0.50  
202b/A 0.37   
202/B 0.93   
203/B – –  
203a/B 0.30   
203b/B 0.32   
202/C 0.90   
HEME LINKS: 
   Average (Å) 
   
C14 SG - HEM CAB   1.90 (0.04) 1.74 (0.01) 1.95 (0.02) 
C17 SG - HEM CAC   1.98 (0.04) 1.86 (0.00) 2.13 (0.07) 
H18 NE2 - FE2 (Å) 2.02 (0.01) 1.99 (0.01) 2.02 (0.03) 
M80 SD - FE2 (Å) 2.30 (0.01) 2.31 (0.01) 2.28 (0.02) 
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CHAPTER 4 
SUMMARY 
 
4.1 Discussion and Conclusion  
 This research is focused on the basic science underlying prostate cancer. Prostate cancer is 
a heterogeneous disease and one of the most typical cancer types in men. It is very difficult to 
diagnose carcinoma early, as there are no symptoms in the early stages. Therefore, prostate cancer 
is the second leading cause of cancer-related death in men in the US. Cancer progression classically 
follows the Warburg effect, a metabolic switch from depending primarily on mitochondrial 
respiration to depending primarily on glycolysis, even in oxygen-rich conditions. Another 
hallmark of cancer is that cancer cells manage to evade apoptosis. Even after more than 70 years 
of cancer research, a full understanding of the underlying mechanism has not yet been achieved.  
Cell signaling, via post translational modifications (PTMs), is one of the most important 
means of regulation in higher organisms. Cell signaling is also most commonly dysregulated in 
different types of cancer, including prostate cancer, in which androgen signaling plays a crucial 
role in driving cell proliferation. Cancer cells use mitochondria as signaling organelles, for cancer 
bioenergetics, and biosynthesis of macromolecules.  
In higher organisms, energy metabolism is completely dependent on mitochondrial 
OXPHOS, including the electron transport chain (ETC), which is also the main source of ROS. 
Cytc, a small heme protein, is an essential component of the ETC where it plays an important role 
in generation of cellular ATP and ROS. Cytc also plays another crucial role in type II apoptosis. 
When Cytc is released from the mitochondria into the cytosol, it binds to Apaf-1 and activates 
downstream caspases. Despite the central role of Cytc in respiration, apoptosis, and ROS formation 
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or scavenging, very little is known about the regulation of its functions. Recent studies indicated 
that Cytc can be posttranslationally modified and regulated through cell signaling pathways. It was 
shown that phosphorylation of Cytc under healthy conditions decisively regulates the protein 
functions, including respiration and apoptosis.  
To date, no study has been performed to investigate structural and functional changes of 
Cytc in cancer, a major gap in knowledge. In this study, we hypothesized that the development of 
prostate cancer causes changes in Cytc posttranslational modifications, which in turn alter the main 
functions of Cytc. Importantly, our preliminary data demonstrate that human Cytc is acetylated on 
lysine 53 residue in human prostate tumor xenografts grown in mice. Mass spectrometry 
unambiguously assigned the acetylation site to Lys-53 in both castrate-resistant and -sensitive 
tumors. This is the first time that Cytc acetylation has been identified in mammals. Strikingly, Lys-
53 is the single and only lysine residue that contained an acetyl group in eight independent tumor 
xenografts, suggesting that this is a cancer-specific modification. Therefore, we hypothesized that 
in prostate cancer the acetylation state of Cytc changes from a “healthy” to a “cancer” state, where 
inhibition of mitochondrial respiration leads to the Warburg effect.  To characterize the effects of 
acetylation in vitro, Lys-53 was mutated to the acetylmimetic glutamine, a non-acetylated arginine 
that carries a positive charge, and to the nonpolar isoleucine as an additional control. Cytc variants 
were overexpressed in bacteria and purified to homogeneity. The Lys53Gln mutant crystallized 
and gave a high resolution structure at 1.31 Å that showed good omit map density for Gln53 and 
confirmed that the mutation caused no significant modification of the overall structure. We were 
able to show with acetylmimetic Cytc that this modification strongly inhibits the participation of 
Cytc in apoptosis. 
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To test the hypothesis that acetylation of Cytc leads to inhibition of mitochondrial 
respiration, COX activity was analyzed with purified Cytc variants. Compared to WT, the 
acetylmimetic Lys53Gln and nonpolar Lys53Ile Cytc mutants showed a 50% decrease in 
respiration. These findings support the hypothesis that acetylation of Cytc down-regulates 
mitochondrial electron flux, decreases cell respiration, and leads to the Warburg effect in cancer. 
To check that the acetylation of Cytc leads to inhibition of apoptosis in cancer, we examined the 
ability of Cytc variants to activate Caspase-3. Remarkably, the acetylmimetic Lys53Gln and 
nonpolar Lys53Ile Cytc were incapable to trigger a robust caspase-3 activation and thus, to induce 
apoptosis. The suppression of apoptosis agrees with the observation that the Lys-53 epitope is 
directly involved in the interaction between Cytc and Apaf-1(Cheng et al., 2016; Zhou et al., 2015). 
Furthermore, we assessed the cardiolipin peroxidase activity of Cytc variants with Amplex 
Red by measuring the fluorescence of resorufin, an oxidation product of Amplex Red. The 
acetylmimetic Lys53Gln and nonpolar Lys53Ile Cytc mutants had lower peroxidase activity than 
that of WT Cytc. Interestingly, the peroxidase activity of the Lys53Arg mutant was higher than 
the activity of the WT, suggesting that it unfolds more easily than WT and the Lys53Gln and 
Lys53Ile Cytc mutants. This data correlates with the apoptotic results, where Lys53Arg Cytc 
mutant demonstrated the highest ability to activate caspase-3 and induce apoptosis, while 
acetylmimetic Lys53Gln and nonpolar Lys53Ile showed a very little ability to trigger apoptosis. 
As expected, we observed that the redox potentials of the Cytc variants were in a range 
between the redox potential of complex III and IV, suggesting the thermodynamic requirement of 
the proteins to properly function within thee ETC. The oxidation and reduction rates of Cytc 
mutants were measured in the reactions with H2O2 and the reductant ascorbate. The acetylmimetic 
Lys53Gln and nonpolar Lys53Ile Cytc mutants were oxidized at about twice the rate compared to 
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the WT and Lys53Arg Cytc controls, suggesting their higher ability to degrade H2O2 and act as a 
stronger ROS scavenger compared to WT. In the reaction with ascorbate, Lys53Gln and Lys53Ile 
Cytc were reduced at a much faster rate compared to WT and Lys53Arg Cytc controls. Their higher 
ability to accept electrons further supports their ROS scavenging capacity.  
We conclude that cancer signaling leads to a change in the Cytc acetylation state, causing 
an inhibition of respiration ("Warburg effect"). It also renders Cytc incapacitated of triggering 
apoptosis, allowing cancer cells to evade programmed cell death.  
  
4.2 Future Directions  
 A translational goal of this work is to improve future diagnosis and therapy, by using Cytc 
acetylation as a predictive biomarker and by targeting the to-be-identified acetylase/deacetylase, 
respectively. It is likely that the extent of Cytc Lys53 acetylation correlates with cancer 
aggressiveness. The first step to test this hypothesis would be a development of a monoclonal 
antibody and to test them on a panel of cancer specimens. 
 Another important project direction would be to functionally characterize acetylmimetic 
Cytc in the mammalian cell culture system. To further confirm the results, mitochondrial function 
would be analyzed in intact cells. Such future studies will include experiments to examine 
mitochondrial membrane potential and ROS production, aconitase activity as a marker of oxidative 
stress, and ROS scavenging markers including MnSOD, CuZnSOD and glutathione peroxidase. 
Additional metabolic readouts will be ATP and lactate production.  
 Efforts will continue to determine the crystal structures of the Lys53Ile and Lys53Arg Cytc 
mutants to see if they help explain the functional differences reported in this study. Molecular 
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dynamics calculations, similar to those analyzed in (Mahapatra et al., 2017) might also elucidate 
the differences. 
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ABSTRACT 
 
THE EFFECT OF ACETYLATION OF CYTOCHROME C ON ITS FUNCTIONS IN 
CANCER 
by 
VIKTORIIA BAZYLIANSKA 
May 2017 
Advisor: Dr. Maik Hüttemann 
Major: Biochemistry and Molecular Biology 
Degree: Master of Science 
Prostate cancer is the second leading cause of cancer death among men in America. The 
progression of cancer goes along with the Warburg effect, a metabolic switch from depending 
primarily on mitochondrial respiration to glycolysis. In addition, cancer cells manage to evade 
apoptosis. Cell signaling, via posttranslational modifications (PTMs), is one of the most important 
means of regulation, and most commonly dysregulated in cancer. In prostate cancer, androgen 
signaling plays a crucial role in driving cell proliferation.  
Mammalian Cytochrome c (Cytc) is a multifunctional protein involved in cellular life and 
death decision. It is an essential component of the electron transport chain (ETC), where it shuttles 
electrons to cytochrome c oxidase (COX) to eventually generate ATP. Cytc also functions as a 
trigger of apoptosis when released into the cytosol. However, its regulation is not well understood. 
Previously, it was shown that Cytc can be posttranslationally modified and regulated by 
phosphorylation through cell signaling pathways, controlling the protein functions.   
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In this study, we demonstrated that development of prostate cancer causes changes in Cytc 
posttranslational modifications which in turn, alter the main protein functions, including 
respiration and apoptosis. The preliminary data demonstrated that human Cytc is acetylated on 
lysine 53 in eight independent castrate-resistant and -sensitive human tumor xenografts, suggesting 
that this is a cancer-specific modification. To characterize the functional effects, Lys-53 was 
mutated to the acetylmimetic glutamine, a non-acetylated arginine that carries a positive charge, 
and to the nonpolar isoleucine as an additional control. Cytc variants were overexpressed in 
bacteria and purified to homogeneity. COX activity, analyzed with purified Cytc variants, 
demonstrated that the acetylmimetic Lys53Gln Cytc showed reduced respiration compared to the 
nonacetylated WT. Remarkably, compared to WT, acetylmimetic Lys53Gln mutant was unable to 
trigger caspase-3 activity and hence, to induce apoptosis. This data suggests that the Lys-53 
epitope is directly involved in the interaction between Cytc and Apaf-1. Our study shows that 
acetylmimetic Lys53Gln causes a reduction of peroxidase activity of Cytc compared to WT 
control, proving the results that Lys53Gln is incapable of triggering apoptosis. We observed that 
the redox potentials of the Cytc variants were in a range between the redox potential of complex 
III and IV, suggesting the ability of proteins to function properly, which was also confirmed by 
spectrophotometric analysis. We also showed that Lys53Gln Cytc mutant has a higher ability to 
degrade H2O2 and act as a stronger ROS scavenger compared to WT. Additionally, Lys53Gln Cytc 
mutant demonstrated a better capacity to accept electrons further supporting its role as ROS 
scavenger. In summary, our data suggest that cell signaling regulates cellular respiration and 
apoptosis via PTMs of Cytc, and suggest distinct regulation of Cytc in cancer.   
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